Browse by Academic Unit (A-Z)

A

Abignano, G, Blagojevic, J, Bissell, L-A orcid.org/0000-0002-2789-4652 et al. (16 more authors) (2019) European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology, 58 (2). key271. pp. 254-259. ISSN 1462-0324

Abignano, G. orcid.org/0000-0002-1479-0133 and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2020) Biomarkers as an opportunity to stratify for outcome in systemic sclerosis. European Journal of Rheumatology, 7 (Supplement 3). S193-S202. ISSN 2147-9720

Abignano, G. orcid.org/0000-0002-1479-0133, Green, L. orcid.org/0000-0003-1620-2443, Eng, S. et al. (2 more authors) (2022) Nailfold Microvascular Imaging by Dynamic Optical Coherence Tomography in Systemic Sclerosis: A Case-Controlled Pilot Study. Journal of Investigative Dermatology, 142 (4). pp. 1050-1057. ISSN 0022-202X

Abignano, G. orcid.org/0000-0002-1479-0133, Hermes, H., Piera-Velazquez, S. et al. (3 more authors) (2021) Global gene expression analysis of systemic sclerosis myofibroblasts demonstrates a marked increase in the expression of multiple NBPF genes. Scientific Reports, 11. 20435. ISSN 2045-2322

Abignano, G., Karadag, D.T., Gundogdu, O. et al. (6 more authors) (2020) P161 Optical coherence tomography of the skin detects scleroderma changes in clinically unaffected skin: an opportunity for early detection of systemic sclerosis. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow (Event Cancelled).

Abignano, G. orcid.org/0000-0002-1479-0133, Mennillo, G.A., Lettieri, G. orcid.org/0000-0002-7422-554X et al. (6 more authors) (2021) UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis. The Journal of Rheumatology, 48 (9). pp. 1422-1426. ISSN 0315-162X

Abignano, G. orcid.org/0000-0002-1479-0133, Temiz Karadağ, D., Gundogdu, O. et al. (6 more authors) (2020) FRI0226 optical coherence tomography of the skin detects scleroderma changes in clinically unaffected skin: an opportunity for early detection of systemic sclerosis. In: EULAR 2020 - Annual European Congress of Rheumatology, 03-06 Jun 2020, Virtual.

Abolhassani, H, El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Arumugakani, G et al. (12 more authors) (2020) Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency. Journal of Clinical Immunology, 40. pp. 277-288. ISSN 0271-9142

Ahmad, HA, Baker, JF, Conaghan, P orcid.org/0000-0002-3478-5665 et al. (5 more authors) (2022) Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept. Arthritis Research and Therapy, 24. 47. ISSN 1478-6354

Ahmad, HA, Baker, JF, Østergaard, M et al. (5 more authors) (2020) Baseline Objective Inflammation by Magnetic Resonance Imaging as a Predictor of Therapeutic Benefit in Early Rheumatoid Arthritis With Poor Prognosis. Arthritis Care & Research, 72 (7). pp. 959-964. ISSN 0893-7524

Ahmad, HA, Baker, JF, Østergaard, M et al. (3 more authors) (2019) Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial. Advances in Therapy, 36 (9). pp. 2384-2393. ISSN 0741-238X

Akthar, M., Nair, N., Carter, L.M. et al. (7 more authors) (2023) Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil. Arthritis Research & Therapy, 25 (1). ARTN 111. ISSN 1478-6354

Akthar, M., Nair, N., Carter, L.M. et al. (5 more authors) (2023) Correction: Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil. Arthritis Research & Therapy, 25 (1). 160. ISSN 1478-6354

Al-Hakim, A., Cull, A., Topping, J. et al. (9 more authors) (2023) Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim. HemaSphere, 7 (8). e934. ISSN 2572-9241

Al-Hakim, A., Mistry, A. and Savic, S. orcid.org/0000-0001-7910-0554 (2022) Improving Diagnosis and Clinical Management of Acquired Systemic Autoinflammatory Diseases. Journal of Inflammation Research, 15. pp. 5739-5755. ISSN 1178-7031

Al-Hakim, A, Poulter, JA orcid.org/0000-0003-2048-5693, Mahmoud, D et al. (9 more authors) (2022) Allogeneic hematopoietic stem cell transplantation for VEXAS syndrome - UK experience. British Journal of Haematology, 199 (5). pp. 777-781. ISSN 0007-1048

Al-Hakim, A and Savic, S orcid.org/0000-0001-7910-0554 (2023) An update on VEXAS syndrome. Expert Review of Clinical Immunology, 19 (2). pp. 203-215. ISSN 1744-666X

Al-Laith, M, Jasenecova, M, Abraham, S et al. (27 more authors) (2019) Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. Trials, 20 (1). 429. p. 429. ISSN 1745-6215

Alase, AA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Vital, EM orcid.org/0000-0003-1637-4755 et al. (3 more authors) (2015) IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism. Journal of Investigative Dermatology, 135 (12). pp. 2935-2943. ISSN 0022-202X

Alcacer-Pitarch, B, Siddle, HJ, Buch, MH et al. (3 more authors) (2011) Foot health needs in people with systemic sclerosis: an audit of foot health care provision. Clinical Rheumatology, 30 (12). pp. 1611-1615. ISSN 0770-3198

Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X, Del Galdo, F. orcid.org/0000-0002-8528-2283 and Marzo-Ortega, H. (2024) Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases. The Lancet Rheumatology, 6 (10). e664-e665. ISSN 2665-9913

Aletaha, D, Kerschbaumer, A, Kastrati, K et al. (41 more authors) (2022) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O'Connor, P et al. (3 more authors) (2019) Reduction in stiffness of proximal leg muscles during the first 6 months of glucocorticoid therapy for giant cell arteritis: A pilot study using shear wave elastography. International Journal of Rheumatic Diseases, 22 (10). pp. 1891-1899. ISSN 1756-1841

Alfuraih, AM orcid.org/0000-0002-4655-7248, O'Connor, P, Tan, AL orcid.org/0000-0002-9158-7243 et al. (4 more authors) (2019) Muscle shear wave elastography in idiopathic inflammatory myopathies: a case–control study with MRI correlation. Skeletal Radiology, 48 (8). pp. 1209-1219. ISSN 0364-2348

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O'Connor, P et al. (2 more authors) (2020) Muscle stiffness in rheumatoid arthritis is not altered or associated with muscle weakness: a shear wave elastography study. Modern Rheumatology, 30 (4). pp. 617-625. ISSN 1439-7595

Alfuraih, AM orcid.org/0000-0002-4655-7248, Tan, AL orcid.org/0000-0002-9158-7243, O’Connor,, P et al. (2 more authors) (2019) The effect of ageing on shear wave elastography muscle stiffness in adults. Aging Clinical and Experimental Research, 31 (12). pp. 1755-1763. ISSN 1594-0667

Anioke, I. orcid.org/0000-0001-7600-4823, Duquenne, L., Parmar, R. et al. (4 more authors) (2024) Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals. Rheumatology, 63 (6). pp. 1720-1732. ISSN 1462-0324

Antinozzi, C. orcid.org/0000-0003-4296-5081, Sgrò, P. orcid.org/0000-0003-4929-2764, Marampon, F. et al. (4 more authors) (2021) Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts. Biology, 10 (6). 491. ISSN 2079-7737

Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis and Rheumatology, 71 (9). pp. 1400-1412. ISSN 2326-5191

Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases, 78 (9). pp. 1151-1159. ISSN 0003-4967

Armitage, K.F. orcid.org/0000-0001-5438-5290, Porter, C.E., Ahmed, S. et al. (19 more authors) (2023) Penicillin allergy status and its effect on antibiotic prescribing, patient outcomes and antimicrobial resistance (ALABAMA): protocol for a multicentre, parallel-arm, open-label, randomised pragmatic trial. BMJ Open, 13 (9). e072253. ISSN 2044-6055

Arnold, J., Carter, L.M., Yusof, M.Y.M. et al. (6 more authors) (2024) ANA-associated arthritis: clinical and biomarker characterization of a population for basket trials. Rheumatology. keae269. ISSN 1462-0324

Arnold, J, Vital, E, Dass, S et al. (5 more authors) (2021) A Personalised Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in Anca-Associated Vasculitis. In: EULAR 2021, 02-05 Jun 2021, Virtual.

Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755, Dass, S et al. (5 more authors) (2022) A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis. Frontiers in Immunology, 12. 803175. ISSN 1664-3224

Arnold, J, Winthrop, K and Emery, P orcid.org/0000-0002-7429-8482 (2021) COVID-19 vaccination and antirheumatic therapy. Rheumatology. keab223. ISSN 1462-0324

Arnold, JE, Vital, EMJ, Dass, S et al. (5 more authors) (2021) P207 A proposal for individually tailored rituximab treatment based on clinical and B-cell biomarkers for remission maintenance in ANCA associated vasculitis. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Online.

Aslam, T, Mahmood, F, Sabanathan, A et al. (2 more authors) (2020) A clinical and radiographic comparison of patients with psoriatic arthritis from different ethnic backgrounds. Rheumatology. keaa298. ISSN 1462-0324

Avanoglu-Guler, A. orcid.org/0000-0001-9866-9797, Campochiaro, C., De Luca, G. et al. (6 more authors) (2024) Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands. Seminars in Arthritis and Rheumatism, 66. 152431. ISSN 0049-0172

Aydin, SZ, Gunal, EK, Ozata, M et al. (4 more authors) (2017) Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission. Clinical and Experimental Rheumatology, 35 (5). pp. 853-856. ISSN 0392-856X

Aydin, SZ, Pay, S, Inanc, N et al. (4 more authors) (2017) Which joints and why do rheumatologists scan in rheumatoid arthritis by ultrasonography? A real life experience. Clinical and Experimental Rheumatology, 35 (3). pp. 508-511. ISSN 0392-856X

B

Backhouse, MR orcid.org/0000-0003-0056-8467, Hensor, EMA orcid.org/0000-0002-5245-4755, White, D et al. (3 more authors) (2013) Concurrent validation of activity monitors in patients with rheumatoid arthritis. Clinical Biomechanics, 28 (4). pp. 473-479. ISSN 0268-0033

Backhouse, MR orcid.org/0000-0003-0056-8467, Keenan, A-M orcid.org/0000-0003-0926-0397, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (8 more authors) (2011) Use of conservative and surgical foot care in an inception cohort of patients with rheumatoid arthritis. Rheumatology, 50 (9). pp. 1586-1595. ISSN 1462-0324

Bagnato, G, Pigatto, E, Bitto, A et al. (15 more authors) (2021) The PREdictor of MAlnutrition in Systemic Sclerosis (PREMASS) Score: A Combined Index to Predict 12 Months Onset of Malnutrition in Systemic Sclerosis. Frontiers in Medicine, 8 (1). 651748. ISSN 2296-858X

Bandini, G. orcid.org/0000-0002-2076-7319, Alunno, A. orcid.org/0000-0003-1105-5640, Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X et al. (14 more authors) (2024) Patients’ unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis. Rheumatology. keae130. ISSN 1462-0324

Bandini, G., Alunno, A., Ruaro, B. et al. (11 more authors) (2024) Unmet needs and treatment preferences concerning digital ulcers in patients with systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool, United Kingdom. Oxford University Press , keae163.171.

Bandini, G., Alunno, A., Ruaro, B. et al. (11 more authors) (2024) P130 Unmet needs and treatment preferences concerning digital ulcers in patients with systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool, UK. Oxford University Press , i90-i91.

Baraliakos, X., Bird, P., Deodhar, A. et al. (15 more authors) (2024) Associations Between Clinical Characteristics and Screening MRI Findings: Exploratory Analysis of the Ongoing Phase 4, Multicenter, Randomized, Controlled STAR Study of Biologic-Naïve Patients with PsA with MRI-Confirmed Axial Involvement. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Baraliakos, X, Conaghan, PG orcid.org/0000-0002-3478-5665, D'Agostino, M-A et al. (5 more authors) (2019) Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities. European Journal of Rheumatology, 6 (1). pp. 37-45. ISSN 2147-9720

Beck, D, Ferrada, M, Sikora, K et al. (19 more authors) (2020) Somatic Mutations in a Single Residue of UBA1 Cause VEXAS, a Severe Adult-Onset Rheumatic Disease Presenting as Relapsing Polychondritis, Polyarteritis Nodosa, or Giant Cell Arteritis. In: ACR Convergence 2020, 05-09 Nov 2020, Online.

Beck, DB, Ferrada, MA, Sikora, KA et al. (59 more authors) (2020) Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. New England Journal of Medicine. NEJMoa2026834. ISSN 0028-4793

Behrens, F, Mease, P, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (8 more authors) (2021) Efficacy of Guselkumab Across BASDAI Components in Treating Axial-Related Symptoms of Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-controlled Studies. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Behrens, F, Mease, PJ, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (8 more authors) (2021) Efficacy of Guselkumab Across Basdai Components in Treating Axial-Related Symptoms of Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Studies. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Behrens, F, Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (8 more authors) (2021) Efficacy of Guselkumab Across Basdai Components in Treating Axial-Related Symptoms of Psoriatic Arthritis: Results from Two Phase-3, Randomized, Placebo-Controlled Studies. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Bellando-Randone, S., Del Galdo, F. orcid.org/0000-0002-8528-2283 and Matucci-Cerinic, M. (2022) Insights into molecular and clinical characteristics of very early systemic sclerosis. Current Opinion in Rheumatology, 34 (6). pp. 351-356. ISSN 1040-8711

Bennett, AN, McGonagle, D, O'Connor, P et al. (5 more authors) (2008) Severity of baseline magnetic resonance imaging–evident sacroiliitis and HLA–B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis & Rheumatism, 58 (11). pp. 3413-3418. ISSN 0004-3591

Berekméri, A, Latzko, A, Alase, A et al. (12 more authors) (2018) Detection of IL-36γ through noninvasive tape stripping reliably discriminates psoriasis from atopic eczema. Journal of Allergy and Clinical Immunology, 142 (3). 988-991.e4. ISSN 0091-6749

Bernstein, J., Li, H., Yea, C. et al. (5 more authors) (2021) A022 on-demand oral treatment with kvd900 for hae attacks achieves rapid exposure and improves patient outcomes. In: 2021 Annual Scientific MeetingAmerican College of Allergy, Asthma & Immunology, 04-08 Nov 2021, New Orleans, Louisiana.

Bernstein, J., Riedl, M., Lumry, W. et al. (3 more authors) (2023) Treatment with Sebetralstat Reduces the Cumulative Symptom Severity of Hereditary Angioedema Attacks in a Phase 2 Trial. In: Journal of Allergy and Clinical Immunology. 2023 AAAAI Annual Meeting, 24 Feb 2023 - 27 Feb 2024, San Antonio, USA. Elsevier , AB130-AB130.

Bertham, DP, Tan, AL orcid.org/0000-0002-9158-7243, Booth, A et al. (4 more authors) (2022) Repeatability of quantitative MRI in patients with rheumatoid arthritis. Radiography, 28 (3). pp. 831-837. ISSN 1078-8174

Bethune, C, Egner, W, Garcez, T et al. (8 more authors) (2019) British Society for Immunology/United Kingdom Primary Immunodeficiency Network consensus statement on managing non‐infectious complications of common variable immunodeficiency disorders. Clinical & Experimental Immunology, 196 (3). pp. 328-335. ISSN 0009-9104

Betteridge, Z, Tansley, S, Shaddick, G et al. (14 more authors) (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. Journal of Autoimmunity, 101. pp. 48-55. ISSN 1756-1841

Bewley, A, Shafi, M, Gorecki, P et al. (4 more authors) (2022) PS08: A prospective noninterventional study to evaluate the psychosocial impact of biological treatment outcomes in patients with moderate-to-severe plaque psoriasis in the UK: interim results. In: British Association of Dermatologists 102nd Annual Meeting, 05-07 Jul 2022, Glasgow, Scotland.

Biglands, JD orcid.org/0000-0002-1161-5022, Erhayiem, B, Fent, G et al. (6 more authors) (2022) No differences in myocardial perfusion between treatment-naive, early rheumatoid arthritis patients and healthy controls. Arthritis and Rheumatology, 75 (1). pp. 141-142. ISSN 2326-5191

Biglands, JD orcid.org/0000-0002-1161-5022, Grainger, AJ, Robinson, P orcid.org/0000-0002-8431-9929 et al. (6 more authors) (2020) MRI in acute muscle tears in athletes: can quantitative T2 and DTI predict return to play better than visual assessment? European Radiology, 30 (12). pp. 6603-6613. ISSN 0938-7994

Bissell, LA, Adu, D and Emery, P orcid.org/0000-0002-7429-8482 (2015) The patient with rheumatoid arthritis, mixed connective tissue disease, polymyositis, Sjögren syndrome , or overlap syndromes. In: Turner, NW, Lameire, N, Goldsmith, DJ, Winearls, CJ, Himmelfarb, J, Remuzzi, G, Bennet, WG, de Broe, ME, Chapman, JR, Covic, A, Jha, V, Sheerin, N and Unwin, R, (eds.) Oxford Textbook of Clinical Nephrology. Oxford University Press . ISBN 9780199592548

Bosello, S.L., Vital, E.M. orcid.org/0000-0003-1637-4755 and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2022) More to B: the growing evidence to inform targeting B cells in scleroderma. Rheumatology, 62 (5). pp. 1730-1732. ISSN 1462-0324

Bowes, J, Budu-Aggrey, A, Huffmeier, U et al. (29 more authors) (2015) Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nature Communications, 6. 6046. ISSN 2041-1723

Bowman, SJ, Everett, CC orcid.org/0000-0002-9788-840X, O'Dwyer, JL orcid.org/0000-0002-7212-6089 et al. (21 more authors) (2017) Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome. Arthritis & Rheumatology, 69 (7). pp. 1440-1450. ISSN 2326-5191

Brady, S., Mott, A., Carlisle, K. et al. (21 more authors) (2024) PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) – a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study. BMJ Open, 14 (6). e084997. ISSN 2044-6055

Braun, J, Baraliakos, X, Deodhar, A et al. (5 more authors) (2019) Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study. Rheumatology (Oxford, England), 58 (5). pp. 859-868. ISSN 1462-0324

Bridgewood, C, Damiani, G, Sharif, K et al. (5 more authors) (2020) Rationale for Evaluating PDE4 Inhibition for Mitigating against Severe Inflammation in COVID-19 Pneumonia and Beyond. The Israel Medical Association journal : IMAJ, 22 (6). pp. 335-339. ISSN 1565-1088

Brown, S orcid.org/0000-0002-1840-3786, Everett, CC orcid.org/0000-0002-9788-840X, Naraghi, K et al. (8 more authors) (2018) Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT. Health Technology Assessment, 22 (34). ISSN 1366-5278

Brown, L-AK, Moran, E, Goodman, A et al. (19 more authors) (2021) Treatment of chronic or relapsing COVID-19 in immunodeficiency. Journal of Allergy and Clinical Immunology, 149 (2). pp. 557-561. ISSN 0091-6749

Bruni, C., Tofani, L., Fretheim, H. et al. (55 more authors) (2023) OP0238 Immunosuppression With Targeted Dmards Reduces Morbidity And Mortality In Pre-Capillary Pulmonary Hypertension Associated With Systemic Sclerosis: A Eustar Analysis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 157-159.

Bryden, SR, Pingen, M orcid.org/0000-0001-5689-9076, Lefteri, DA et al. (16 more authors) (2020) Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site. Science Translational Medicine, 12 (527). eaax2421. ISSN 1946-6234

Bryon, J., Wasson, C.W. orcid.org/0000-0001-6558-4738, Koeppen, K. et al. (7 more authors) (2024) Systemic Sclerosis dermal fibroblast exosomes trigger a Type 1 interferon response in keratinocytes through the TBK/JAK/STAT signalling axis. Arthritis & Rheumatology. ISSN 2326-5191

Bryon, J.A., Wasson, C., Ross, R.L. et al. (2 more authors) (2023) Systemic Sclerosis Dermal Fibroblast-derived Exosomes trigger a Type I Interferon Response in Keratinocytes, through Tank Binding Kinase 1. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Buch, MH orcid.org/0000-0002-8962-5642, Boyle, DL, Rosengren, S et al. (10 more authors) (2009) Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study. Annals of the Rheumatic Diseases, 68 (7). pp. 1220-1227. ISSN 0003-4967

Buch, MH orcid.org/0000-0002-8962-5642, Vital, EM orcid.org/0000-0003-1637-4755 and Emery, P orcid.org/0000-0002-7429-8482 (2008) Abatacept in the treatment of rheumatoid arthritis. Arthritis Research and Therapy, 10 Suppl 1 (S5). S5-. ISSN 1478-6354

Burke, MJ, Scott, JNF, Minshull, TC et al. (6 more authors) (2022) A bovine antibody possessing an ultralong complementarity-determining region CDRH3 targets a highly conserved epitope in sarbecovirus spike proteins. Journal of Biological Chemistry, 298 (12). 102624. ISSN 0021-9258

Burska, A, El-Jawhari, J, Wu, J orcid.org/0000-0001-6093-599X et al. (6 more authors) (2020) Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis. Clinical and Experimental Rheumatology. ISSN 0392-856X

Burska, AN orcid.org/0000-0003-3321-9087, Thu, A, Parmar, R et al. (7 more authors) (2019) Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis. Rheumatology, 58 (11). pp. 2015-2024. ISSN 1462-0324

Burska, A., Rodríguez-Carrio, J., Biesen, R. et al. (14 more authors) (2023) Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open, 9 (1). e002876. ISSN 2056-5933

Burska, AN orcid.org/0000-0003-3321-9087, Giannoudis, PV, Tan, BH et al. (3 more authors) (2020) Dynamics of Early Signalling Events during Fracture Healing and Potential Serum Biomarkers of Fracture Non-Union in Humans. Journal of Clinical Medicine, 9 (2). 492.

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2018) On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International, 38 (12). pp. 2225-2231. ISSN 0172-8172

Bykerk, VP, Burmester, GR, Combe, BG et al. (4 more authors) (2019) Correction to: On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis. Rheumatology International. ISSN 0172-8172

C

Calabrese, LH, Emery, P orcid.org/0000-0002-7429-8482, Kivitz, AJ et al. (1 more author) (2020) Evolving treatment paradigms for rheumatoid arthritis: Translating comprehensive patient evaluations into personalized therapy. Seminars in Arthritis and Rheumatism, 50 (6). 1549. ISSN 0049-0172

Campbell, TM, Churchman, SM orcid.org/0000-0003-0172-3975, Gomez, A et al. (4 more authors) (2016) Mesenchymal Stem Cell Alterations in Bone Marrow Lesions in Patients With Hip Osteoarthritis. Arthritis and Rheumatology, 68 (7). pp. 1648-1659. ISSN 2326-5191

Campochiaro, C. orcid.org/0000-0001-6806-3794, Hoffmann-Vold, A.-M. orcid.org/0000-0001-6467-7422, Avouac, J. et al. (90 more authors) (2022) Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis. Rheumatology, 62 (7). pp. 2483-2491. ISSN 1462-0324

Caricchio, R, Abbate, A, Gordeev, I et al. (14 more authors) (2021) Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19 A Randomized Clinical Trial. JAMA, 326 (3). pp. 230-239. ISSN 0098-7484

Carter, C, Hughes, P, McHugh, A et al. (4 more authors) (2021) SARS-CoV-2 diagnostics: Towards a more comprehensive approach to routine patient testing. Journal of Immunological Methods, 494. 113044. ISSN 0022-1759

Carter, L.M., Yusof, M.Y.M., Wigston, Z. et al. (5 more authors) (2024) Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology. Annals of the Rheumatic Diseases, 83 (10). pp. 1322-1334. ISSN 0003-4967

Carter, LM, Alase, A, Wigston, Z et al. (8 more authors) (2022) OA09 Gene expression analysis reveals distinct ancestry-specific profiles associated with response to rituximab in SLE. In: Rheumatology. UNSPECIFIED. Oxford University Press , i4-i5.

Carter, LM orcid.org/0000-0002-8724-5937, Alase, A, Wigston, Z et al. (10 more authors) (2023) Gene expression and autoantibody analysis reveals distinct ancestry-specific profiles associated with response to rituximab in refractory systemic lupus erythematosus. Arthritis & Rheumatology, 75 (5). pp. 697-710. ISSN 2326-5191

Carter, LM orcid.org/0000-0002-8724-5937, McGonagle, D, Vital, EM orcid.org/0000-0003-1637-4755 et al. (1 more author) (2022) Applying Early Intervention Strategies to Autoimmune Skin Diseases. Is the Window of Opportunity Preclinical? A Dermato-Rheumatology Perspective. Journal of Investigative Dermatology, 142 (3). pp. 944-950. ISSN 0022-202X

Caseley, EA orcid.org/0000-0001-7591-143X, Lara-Reyna, S, Poulter, JA orcid.org/0000-0003-2048-5693 et al. (6 more authors) (2022) An Atypical Autoinflammatory Disease Due to an LRR Domain NLRP3 Mutation Enhancing Binding to NEK7. Journal of Clinical Immunology, 42 (1). pp. 158-170. ISSN 0271-9142

Chandler, F., Reddy, P.A.N., Bhutda, S. et al. (20 more authors) (2024) Molecular glues that inhibit deubiquitylase activity and inflammatory signalling. [Preprint]

Chang, L. orcid.org/0009-0003-5223-7616, Gardner, L. orcid.org/0000-0002-9397-401X, House, C. et al. (5 more authors) (2023) Comparison of Transcriptomic Changes in Survivors of Exertional Heat Illness with Malignant Hyperthermia Susceptible Patients. International Journal of Molecular Sciences, 24 (22). 16124. ISSN 1661-6596

Chang, L. orcid.org/0009-0003-5223-7616, Motley, R., Daly, C.L. et al. (3 more authors) (2024) An Association between OXPHOS-Related Gene Expression and Malignant Hyperthermia Susceptibility in Human Skeletal Muscle Biopsies. International Journal of Molecular Sciences, 25 (6). 3489. ISSN 1661-6596

Chang, L., Topping, J., Nadat, F. et al. (13 more authors) (2024) OP0006 CHARACTERISATION OF GENETIC LANDSCAPE AND NOVEL INFLAMMATORY BIOMARKERS IDENTIFIES NOVEL TREATMENT TARGETS IN ADULT-ONSET STILL’S DISEASE. In: Annals of the Rheumatic Diseases. EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria. BMJ , pp. 200-201.

Chapman, L.S. orcid.org/0000-0002-4207-2809, Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X, Pauling, J.D. et al. (13 more authors) (2024) Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group. Seminars in Arthritis and Rheumatism, 65. 152372. ISSN 0049-0172

Chapman, L.S., Flurey, C., Redmond, A.C. orcid.org/0000-0002-8709-9992 et al. (9 more authors) (2023) Living with foot and ankle disorders in rheumatic and musculoskeletal diseases: a thematic synthesis of qualitative studies to inform the work of the Outcome Measures in Rheumatology (OMERACT) Foot and Ankle Working Group. In: British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester - Hybrid.

Chapman, LS, Backhouse, M orcid.org/0000-0003-0056-8467, Bearne, L et al. (19 more authors) (2022) Management of foot health in people with inflammatory arthritis: British Society for Rheumatology guideline scope. Rheumatology. ISSN 1462-0324

Cheng, Z, Do, TD orcid.org/0000-0002-5668-2181, Mankia, K et al. (7 more authors) (2020) Dysbiosis in the Oral Microbiomes of anti-CCP Positive Individuals at Risk of Developing Rheumatoid Arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Cheung, W.C., Shukla, R., Dumitru, R. et al. (8 more authors) (2023) POS0627 Blood-Based Protein Biomarkers Are Associated With Subclinical Cardiovascular Abnormalities As Defined By Cardiovascular Magnetic Resonance Imaging In Systemic Sclerosis (Ssc) Patients. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 587-588.

Cipolletta, E, Di Matteo, A orcid.org/0000-0003-0867-7051, Incorvaia, A et al. (3 more authors) (2019) When chest pain is not "just" Tietze's syndrome: a case of non-Hodgkin's lymphoma. Clinical and Experimental Rheumatology, 37 (4). p. 714. ISSN 0392-856X

Cipriani, P., Ruscitti, P., Di Cola, I. et al. (6 more authors) (2022) Fibroblast expression of CD248 may contribute to exacerbation of microvascular damage during systemic sclerosis. Rheumatology, 62 (3). pp. 1317-1325. ISSN 1462-0324

Ciurtin, C, Majeed, Y, Naylor, J et al. (4 more authors) (2010) TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan. BMC Musculoskeletal Disorders, 11 (1). 111. ISSN 1471-2474

Clark, S, Thomas, C, Fallaha, D et al. (5 more authors) (2021) DALES, Drug Allergy Labels in Elective Surgical patients: a prospective multicentre cross-sectional study of incidence, risks, and attitudes in penicillin de-labelling strategies. British Journal of Anaesthesia, 127 (6). pp. 897-904. ISSN 0007-0912

Coates, L, Bushmakin, A, FitzGerald, O et al. (5 more authors) (2019) Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Coates, L, Mease, P, Gladman, D et al. (8 more authors) (2019) Long-term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study. In: 2019 ACR/ARP Annual Meeting Minutes, 08-13 Nov 2019, Atlanta, Georgia, USA.

Coates, L, Mease, P, Gladman, D et al. (8 more authors) (2020) Long-term safety of filgotinib in patients with PsA: week 52 safety data from a Phase 2 open-label extension study. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Cancelled.

Coates, L, Merola, J, Mease, P et al. (10 more authors) (2019) The Performance Characteristics of Composite Measures Used in a Randomized Trial Examining Etanercept and Methotrexate as Monotherapy or in Combination in Patients with Psoriatic Arthritis. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Coates, LC orcid.org/0000-0002-4756-663X, Lubrano, E, Perrotta, FM et al. (3 more authors) (2019) What Should Be the Primary Target of “Treat to Target” in Psoriatic Arthritis? Journal of Rheumatology, 46 (1). pp. 38-42. ISSN 0315-162X

Coates, LC orcid.org/0000-0002-4756-663X, Mahmood, F, Freeston, J orcid.org/0000-0003-0358-338X et al. (3 more authors) (2020) Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial. Rheumatology, 59 (4). kez369. pp. 807-810. ISSN 1462-0324

Coates, LC orcid.org/0000-0002-4756-663X, Moverley, AR, McParland, L et al. (7 more authors) (2015) Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised, controlled trial. The Lancet, 386 (10012). pp. 2489-2498. ISSN 0140-6736

Coates, L., Gossec, L., Contre, C. et al. (8 more authors) (2022) 2127: Guselkumab Provides Continued Improvement in Key Domains of Psoriatic Arthritis Through 2 Years. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 4214-4216.

Coates, L., Gossec, L., Contre, C. et al. (8 more authors) (2022) POS1017 Guselkumab Provides Continued Improvement In Key Domains Of Psoriatic Arthritis Through 2 Years. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 818-819.

Coates, L, Gladman, D, Van den Bosch, F et al. (10 more authors) (2020) Long-term Outcomes with Filgotinib, an Oral Selective Janus Kinase 1 Inhibitor: 100-week Data from an Open-label Extension (OLE) Study in Patients with Active Psoriatic Arthritis (PsA). In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Coates, L, Mease, P, Gladman, D et al. (8 more authors) (2020) Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020.

Coates, L, Ritchlin, C, Gossec, L et al. (12 more authors) (2020) Guselkumab Provides Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2020, 05-09 Nov 2021, Virtual.

Coates, L, Ritchlin, C, Gossec, L et al. (12 more authors) (2021) Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Coates, LC, Baraliakos, X, Blanco, FJ et al. (17 more authors) (2021) The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status? Arthritis Care & Research, 73 (6). pp. 856-860. ISSN 2151-464X

Coates, LC, Birt, J, Kronbergs, A et al. (4 more authors) (2021) Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Coates, LC, Garrood, T, Gullick, N et al. (8 more authors) (2021) Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Coates, LC, Garrood, T, Gullick, N et al. (8 more authors) (2022) Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Rheumatology. ISSN 1462-0324

Coates, LC, Gladman, DD, Van den Bosch, F et al. (10 more authors) (2021) Long-Term Outcomes with Filgotinib, an Oral Preferential Janus Kinase 1 Inhibitor: 100-Week Data from an Open-Label Extension (OLE) Study in Patients with PSA. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Coates, LC, Mease, PJ, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (8 more authors) (2021) Effect of Filgotinib on Pasdas: Drivers of Low and Very Low Activity up to Week 100. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Merola, JF, Mease, PJ et al. (10 more authors) (2020) Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis. Rheumatology. keaa271. ISSN 1462-0324

Coates, LC, O'Dwyer, J orcid.org/0000-0002-7212-6089, Meads, D et al. (3 more authors) (2022) Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era. The Lancet Rheumatology, 4 (6). E390-E391. ISSN 2665-9913

Coates, LC orcid.org/0000-0002-4756-663X, Orbai, A-M, Morita, A et al. (6 more authors) (2018) Achieving minimal disease activity in psoriatic arthritis predicts meaningful improvements in patients’ health-related quality of life and productivity. BMC Rheumatology, 2 (1). 24. ISSN 2520-1026

Coates, LC, Ritchlin, CT, Gossec, L et al. (12 more authors) (2021) Guselkumab Provides Sustained Domain-Specific and Comprehensive Efficacy as Assessed using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Ritchlin, CT, Gossec, L et al. (12 more authors) (2021) Guselkumab Provides Domain-Specific and Comprehensive Efficacy as Assessed using Composite Endpoints in Patients with Active Psoriatic Arthritis. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Coates, LC, Soriano, E, Corp, N et al. (31 more authors) (2021) The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Treatment Recommendations 2021. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Soriano, ER, Corp, N et al. (42 more authors) (2022) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature Reviews Rheumatology, 18 (8). pp. 465-479. ISSN 1759-4790

Coccia, C., Bonomi, F., Cricchio, A.L. et al. (11 more authors) (2024) The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases. Biomedicines, 12 (8). 1760. ISSN 2227-9059

Coe, J, Kudva, S and Shams, K orcid.org/0000-0002-8145-5351 (2022) Matching the dose to the disease: Successful treatment of recalcitrant pyoderma gangrenosum using high-dose secukinumab. Dermatologic Therapy, 35 (9). e15669. ISSN 1396-0296

Colalillo, A., Hachulla, E., Pellicano, C. et al. (35 more authors) (2024) Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. Chest Journal, 166 (4). pp. 837-844. ISSN 0012-3692

Colalillo, A., Pellicano, C., Ananyeva, L.P. et al. (12 more authors) (2023) Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. Arthritis Care & Research. ISSN 2151-464X

Cooles, FAH, Tarn, J, Lendrem, DW et al. (19 more authors) (2022) Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming. Annals of the Rheumatic Diseases, 81 (9). pp. 1214-1223. ISSN 0003-4967

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) The RA-MAP Consortium: A working model for academia-industry collaboration. Nature Reviews Rheumatology, 14 (1). pp. 53-60. ISSN 1759-4790

Cope, AP, Barnes, MR, Belson, A et al. (33 more authors) (2018) Erratum: The RA-MAP Consortium: a working model for academia–industry collaboration. Nature Reviews Rheumatology, 14 (2). p. 119. ISSN 1759-4790

Corinaldesi, C., Ross, R.L., Abignano, G. orcid.org/0000-0002-1479-0133 et al. (8 more authors) (2021) Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition. International Journal of Molecular Sciences, 22 (6). 2894. ISSN 1661-6596

Corradini, D, Di Matteo, A, Emery, P orcid.org/0000-0002-7429-8482 et al. (1 more author) (2021) How should we treat palindromic rheumatism? A systematic literature review. Arthritis and Rheumatology, 51 (1). pp. 266-277. ISSN 2326-5191

Coyle, C., Watson, L., Brooke, M. et al. (25 more authors) (2023) P174 Psoriatic arthritis patients in the UK have a lower quality of life than patients in mainland Europe - an analysis from the ASSIST study. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Coyle, C., Watson, L., Whately-Smith, C. et al. (28 more authors) (2024) How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients. Rheumatology. kead679. ISSN 1462-0324

Coyle, C., Whately-Smith, C., Brooke, M. et al. (24 more authors) (2022) 1028: How Does PsAID Implementation Affect Treatment Intensification and Patient Satisfaction in PsA? In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2040-2042.

Crawshaw, DP, Helliwell, PS, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (3 more authors) (2010) Exercise therapy after corticosteroid injection for moderate to severe shoulder pain: large pragmatic randomised trial. BMJ, 340. c3037. ISSN 1468-5833

Crowley, A., Siegel, L., Wickersham, P. et al. (6 more authors) (2023) The Impact of Baseline BMI and Physical Activity on Upadacitinib Treatment Response: A Post Hoc Analysis of Patients with Ankylosing Spondylitis from the SELECT-AXIS 2 Study. In: ACR Convergence 2023, 10-15 Nov 2023, San Diego, CA.

Csomos, K, Ujhazi, B, Blazso, P et al. (47 more authors) (2022) Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells. Nature Immunology, 23 (8). pp. 1256-1272. ISSN 1529-2908

Curtis, J.R. orcid.org/0000-0002-8907-8976, Emery, P. orcid.org/0000-0002-7429-8482, Downie, B. orcid.org/0000-0001-8278-722X et al. (5 more authors) (2024) Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis. Rheumatology and Therapy, 11 (1). pp. 177-189. ISSN 2198-6576

Curtis, J.R., Emery, P. orcid.org/0000-0002-7429-8482, Kricorian, G. et al. (4 more authors) (2023) Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis. Journal of Rheumatology, 50 (9). pp. 1114-1120. ISSN 0315-162X

Curtis, JR, Emery, P orcid.org/0000-0002-7429-8482, Karis, E et al. (5 more authors) (2021) Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission on Combination Therapy: A Randomized, Double‐Blind Trial. Arthritis and Rheumatology, 73 (5). pp. 759-768. ISSN 2326-5191

Curtis, JR, Stolshek, B, Emery, P orcid.org/0000-0002-7429-8482 et al. (6 more authors) (2023) Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology, 29 (1). pp. 16-22. ISSN 1076-1608

D

DI Donato, S., Ross, R., Karanth, R. et al. (6 more authors) (2024) OP0314 Interferon score as a novel trial enrichment tool to predict clinical outcomes in patients with limited cutaneous systemic sclerosis. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Dand, N. orcid.org/0000-0002-1805-6278, Stuart, P.E., Bowes, J. et al. (82 more authors) (2023) GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. [Preprint]

Danzo, F., Gjeloshi, K., Abignano, G. et al. (4 more authors) (2020) P159 Current patient reported outcomes (PROs) poorly reflect changes in lung function in patients with systemic sclerosis. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow (Event Cancelled).

Danzo, F., Gjeloshi, K., Lettieri, G. et al. (6 more authors) (2020) Severity of hand vascular involvement as assessed by MRI Digital Artery Volume Index (DAVIX©) predicts worsening of clinical parameters and patient reported outcomes in scleroderma. In: British Society for Rheumatology Annual Conference 2020, (Conference was cancelled).

David, P. orcid.org/0000-0003-0075-5895, Di Matteo, A., Hen, O. et al. (9 more authors) (2024) Poly-Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes. Arthritis & Rheumatology, 76 (4). pp. 510-521. ISSN 2326-5191

David, P. orcid.org/0000-0003-0075-5895, Sinha, S., Iqbal, K. et al. (27 more authors) (2024) MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C). eBioMedicine, 104. 105136. ISSN 2352-3964

De Lorenzis, E., Del Galdo, F., Natalello, G. et al. (10 more authors) (2024) Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression. American Journal of Respiratory and Critical Care Medicine. ISSN 1073-449X

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Kakkar, V., Di Donato, S. et al. (13 more authors) (2024) Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets. RMD Open, 10 (1). e003216. ISSN 2056-5933

De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (13 more authors) (2023) AB0881 clinical trajectories of multifactorial hand function deterioration in systemic sclerosis. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (4 more authors) (2023) P159 Clinical trajectories and predictors of hand function deterioration in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E., Kakkar, V., Ross, R. et al. (11 more authors) (2022) POS0876 Serum Interferon Score Predicts Severity Of Patient Reported Hand Disability In Systemic Sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 733-734.

De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 971.

De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) OA28 CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis: rationale for a biological target driven basket trial across disease subsets. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Mor, A., Ross, R.L. et al. (4 more authors) (2024) Serum CCL24 as a biomarker of fibrotic and vascular disease severity in Systemic Sclerosis. Arthritis Care & Research, 76 (9). pp. 1269-1277. ISSN 2151-464X

De Lorenzis, E., Natalello, G., Di Donato, S. et al. (6 more authors) (2023) AB0841 concordance and prognostic relevance of different definitions of systemic sclerosis interstitial lung disease progression. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

De Lorenzis, E., Natalello, G., Pellegrino, G. et al. (29 more authors) (2024) Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. keae532. ISSN 1462-0324

De Lorenzis, E., Rindone, A., Di Donato, S. et al. (1 more author) (2023) Circulating extracellular vesicles in the context of interstitial lung disease related to systemic sclerosis: A scoping literature review. Autoimmunity Reviews, 22 (9). 103401. ISSN 1568-9972

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Wasson, C.W. and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2023) Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives. Journal of Scleroderma and Related Disorders. ISSN 2397-1983

De Marco, G, Berekméri, A, Coates, LC et al. (10 more authors) (2019) Non Topical Pharmacological Treatment of Early, Untreated (DMARD-Naive, Systematic Therapy-Naive) Psoriatic Disease: a Systematic Review. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 904.

Deane, K.D., Holers, V.M., Emery, P. orcid.org/0000-0002-7429-8482 et al. (9 more authors) (2024) Therapeutic interception in individuals at risk of rheumatoid arthritis to prevent clinically impactful disease. Annals of the Rheumatic Diseases. ISSN 0003-4967

Deibel, E. orcid.org/0000-0003-4652-9826, Carreira, P.E., Vonk, M. orcid.org/0000-0002-2266-9907 et al. (61 more authors) (2024) Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time? Arthritis Care & Research, 76 (1). pp. 88-97. ISSN 2151-464X

Del Galdo, F. orcid.org/0000-0002-8528-2283, Bissell, L.A., Huang, S. et al. (4 more authors) (2023) POS0338 Development And Validation Of Ranked Composite Important Difference (RCID) Score In Diffuse Cutaneous Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 416.

Del Galdo, F. orcid.org/0000-0002-8528-2283, Hartley, C. and Allanore, Y. (2020) Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials. The Lancet Rheumatology, 2 (3). e173-e184. ISSN 2665-9913

Del Galdo, F. orcid.org/0000-0002-8528-2283, Khanna, D., Crater, C. et al. (6 more authors) (2023) AB0808 a proof of biological concept trial of CM101 to target CCL24 in systemic sclerosis: a biomarker informed, precision medicine approach. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Del Galdo, F. orcid.org/0000-0002-8528-2283, Lescoat, A., Conaghan, P.G. et al. (24 more authors) (2023) OP0234 2023 Update Of Eular Recommendations For The Treatment Of Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 154-155.

Del Galdo, F. orcid.org/0000-0002-8528-2283, Lescoat, A., Conaghan, P.G. orcid.org/0000-0002-3478-5665 et al. (23 more authors) (2025) EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Annals of the Rheumatic Diseases, 84 (1). pp. 29-40. ISSN 0003-4967

Del Galdo, F. orcid.org/0000-0002-8528-2283, Tian, Y., Di Donato, S. et al. (1 more author) (2023) The Patient Journey to a First Diagnosis of Systemic Sclerosis: Temporal Disease Pattern Identification Using Machine Learning and Data Mining Among US and Japanese Patients. In: ACR Convergence 2023, 10-15 Nov 2023, San Diego, California.

Denman, S, Smith, H, Arumugakani, G et al. (2 more authors) (2022) Cost effectiveness of personalised omalizumab dosing for chronic spontaneous urticaria. Clinical and Experimental Dermatology, 47 (11). pp. 2002-2005. ISSN 0307-6938

Denton, C.P. orcid.org/0000-0003-3975-8938, De Lorenzis, E., Roblin, E. et al. (27 more authors) (2023) Management of systemic sclerosis: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 7 (1). rkad022. ISSN 2514-1775

Denton, C.P., De Lorenzis, E., Roblin, E. et al. (27 more authors) (2024) The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Rheumatology. keae394. ISSN 1462-0324

Denton, C.P., De Lorenzis, E., Roblin, E. et al. (27 more authors) (2024) The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary. Rheumatology. keae390. ISSN 1462-0324

Denton, C.P. orcid.org/0000-0003-3975-8938, del Galdo, F. orcid.org/0000-0002-8528-2283, Khanna, D. et al. (12 more authors) (2023) Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis. Rheumatology, 62 (1). pp. 234-242. ISSN 1462-0324

Deodhar, A, Helliwell, P, Boehncke, W-H et al. (8 more authors) (2020) P262 Guselkumab, an anti-interleukin-23p19 monoclonal antibody, in patients with active PsA who were biologic-naïve or prior TNFα inhibitor-treated: week 24 results of a Phase 3, randomised, double-blind, placebo-controlled study. In: British Society for Rheumatology Annual Conference, 20-22 Apr 2020, Online.

Deodhar, A, Helliwell, P, Boencke, W-H et al. (7 more authors) (2019) Guselkumab, an Anti-interleukin-23p19 Monoclonal Antibody, in Patients with Active Psoriatic Arthritis Who Were Biologic-Naïve or Prior TNFα Inhibitor-Treated: Week 24 Results of a Phase 3, Randomized, Double-blind, Placebo-controlled Study. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, GA, USA.

Deodhar, A, Helliwell, P, Boencke, W-H et al. (8 more authors) (2020) GUSELKUMAB, AN ANTI-INTERLEUKIN-23P19-SUBUNIT MONOCLONAL ANTIBODY, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO WERE BIOLOGIC-NAIVE OR PRIOR TNF alpha INHIBITOR-TREATED: WEEK 24 RESULTS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. In: 22nd PANLAR Congress, 12-15 Aug 2020, Miami, Florida, USA.

Deodhar, A, Kirkham, B, Rahman, P et al. (6 more authors) (2020) P277 Assessment of disease activity using RAPID3 and evaluation of treatment effect of guselkumab in patients with PsA: results from a randomised placebo-controlled Phase 2 clinical trial. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Cancelled.

Deodhar, A, Helliwell, PS, Boehncke, W-H et al. (9 more authors) (2020) Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial. The Lancet, 395 (10230). pp. 1115-1125. ISSN 0140-6736

Di Battista, M., Barsotti, S., Orlandi, M. et al. (5 more authors) (2021) One year in review 2021: systemic sclerosis. Clinical and Experimental Rheumatology, 39 (4). S3-S12. ISSN 0392-856X

Di Donato, S., Huang, S., Pauling, J.D. et al. (4 more authors) (2024) Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease. Seminars in Arthritis and Rheumatism, 68. 152521. ISSN 0049-0172

Di Donato, S., Hughes, M., Geloshi, K. et al. (6 more authors) (2023) P156 Evidence of Type I interferon activation during vascular manifestations of systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Di Luigi, L., Duranti, G., Antonioni, A. et al. (9 more authors) (2020) The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species. Antioxidants, 9 (9). 786. ISSN 2076-3921

Di Matteo, A orcid.org/0000-0003-0867-7051, Mankia, K, Wakefield, RJ orcid.org/0000-0001-5352-8683 et al. (1 more author) (2020) Which joints and what pathological findings should be evaluated on ultrasound in CCP+ at-risk individuals? The fifth MTP joint for bone erosions is a good starting point. Response to: ‘Pisotriquetral arthritis: ‘forgotten’ joint in ultrasound imaging of the wrist’ by Becciolini et al. Annals of the Rheumatic Diseases. ISSN 0003-4967

Di Matteo, A., Bathon, J.M. and Emery, P. orcid.org/0000-0002-7429-8482 (2023) Rheumatoid arthritis. The Lancet, 402. 10416. pp. 2019-2033. ISSN 0140-6736

Di Matteo, A. orcid.org/0000-0003-0867-7051, Mankia, K. orcid.org/0000-0002-7945-6582, Garcia-Montoya, L. et al. (5 more authors) (2024) Utility of testing for third-generation anticyclic citrullinated peptide (anti-CCP3) antibodies in individuals who present with new musculoskeletal symptoms but have a negative second-generation anticyclic citrullinated peptide (anti-CCP2) antibody test. RMD Open, 10 (2). e003927. ISSN 2056-5933

Di Matteo, A., Smerilli, G., Di Donato, S. et al. (46 more authors) (2024) Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study. Annals of the Rheumatic Diseases, 83 (7). pp. 847-857. ISSN 0003-4967

Di Matteo, A, Duquenne, L, Cipolletta, E et al. (6 more authors) (2022) Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum. Rheumatology, 61 (8). pp. 3192-3200. ISSN 1462-0324

Di Matteo, A orcid.org/0000-0003-0867-7051, Mankia, K, Azukizawa, M et al. (1 more author) (2020) The Role of Musculoskeletal Ultrasound in the Rheumatoid Arthritis Continuum. Current Rheumatology Reports, 22 (8). 41. ISSN 1523-3774

Di Matteo, A, Mankia, K, Duquenne, L et al. (5 more authors) (2020) Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis. Annals of the Rheumatic Diseases, 79 (7). pp. 901-907. ISSN 0003-4967

Di Matteo, A orcid.org/0000-0003-0867-7051, Mankia, K, Duquenne, L et al. (6 more authors) (2020) Third-Generation Anti–Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis. Arthritis & Rheumatology, 72 (11). pp. 1820-1828. ISSN 2326-5191

Di Matteo, A orcid.org/0000-0003-0867-7051, Mankia, K, Nam, JL et al. (5 more authors) (2020) In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis. Rheumatology. ISSN 1462-0324

Dixon, PH, Levine, AP, Cebola, I et al. (21 more authors) (2022) GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements. Nature Communications, 13 (1). 4840. ISSN 2041-1723

Dubash, S orcid.org/0000-0002-9303-7122, Alabas, O, Michelena, X et al. (8 more authors) (2020) SAT0413 Dactylitis is associated with disease severity and ultrasound defined erosive damage in very early, DMARD naïve Psoriatic arthritis. In: European League Against Rheumatism (EULAR) 2020, 03-06 Jun 2020, Online.

Dubash, S, Alabas, OA, Michelena, X et al. (7 more authors) (2021) Dactylitis is associated with greater disease severity, CRP, ultrasound determined synovitis, and erosive damage in DMARD-naïve early PsA. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Dubash, S, Alabas, OA, Michelena, X et al. (7 more authors) (2021) Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Dubash, SR, Alabas, OA, Michelena, X et al. (8 more authors) (2021) Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naïve early psoriatic arthritis. Rheumatology Advances in Practice, 5 (3). rkab086. ISSN 2514-1775

Duckworth, E., Feener, E., Yea, C. et al. (3 more authors) (2022) Rapid Plasma Kallikrein Inhibition Following Oral KVD900 is Associated With Early Symptom Relief in Patients With Hereditary Angioedema. In: 2022 AAAAI Annual Meeting, 25-28 Feb 2022, Phoenix, Arizona.

Dumitru, R.B., Bissell, L., Erhayiem, B. et al. (8 more authors) (2023) Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change. ACR Open Rheumatology, 5 (2). pp. 71-80. ISSN 2578-5745

Dumitru, R.B., Goodall, A., Broadbent, D. et al. (6 more authors) (2020) FRI0236 First pilot study of T1 mapping MRI with ECV measurement of peripheral muscle in systemic sclerosis patients shows diffuse fibrosis. In: Annals of the Rheumatic Diseases. EULAR 2020 - European E-Congress of Rheumatology, 03-06 Jun 2020, Online. BMJ , p. 702.

Dumusc, A, Ng, W-F, James, K et al. (27 more authors) (2018) Comparison of ESSDAI and ClinESSDAI in potential optimization of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry. Swiss Medical Weekly, 148 (56). w14588. ISSN 1424-7860

Duquenne, L, Gul, H and Emery, P (2019) Safety evaluation of Adalimumab in immune-mediated inflammatory disorders: a rheumatological point of view. Expert opinion on drug safety, 8 (1). ISSN 1474-0338

Duquenne, L. orcid.org/0000-0001-7631-0986, Hensor, E.M. orcid.org/0000-0002-5245-4755, Wilson, M. et al. (11 more authors) (2023) Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification. Annals of Internal Medicine, 176 (8). pp. 1027-1036. ISSN 0003-4819

Duquenne, L, Chowdhury, R, Mankia, K et al. (1 more author) (2020) The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on “At-Risk” Individuals. Frontiers in Medicine, 7. 587827. ISSN 2296-858X

Dutton, K, Psarras, A, El-Sherbiny, Y orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2018) OP0124 In sle patients in sustained low disease activity, novel interferon assays predict flares and glucocorticoid requirements. In: Annual European Congress of Rheumatology, EULAR 2018, 13-16 Jun 2018, Amsterdam, Netherlands.

E

El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Hensor, E orcid.org/0000-0002-5245-4755 et al. (3 more authors) (2016) Surface Tetherin Is A Novel Cell-Specific Biomarker for Interferon Response in Systemic Lupus Erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 546.

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A et al. (11 more authors) (2020) B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. Arthritis & Rheumatology, 72 (5). pp. 769-779. ISSN 2326-5191

El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Psarras, A, Yusof, MYM et al. (8 more authors) (2018) Publisher Correction: A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features. Scientific Reports, 8. ARTN 14846. ISSN 2045-2322

Elhai, M., Sritharan, N., Boubaya, M. et al. (167 more authors) (2022) Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology, 4 (11). e785-e794. ISSN 2665-9913

Elies, J, Liakouli, V, Abignano, G et al. (6 more authors) (2017) SCLERODERMA FIBROBLASTS SUPPRESS ANGIOGENESIS VIA TGF-beta/CAVEOLIN-DEPENDENT SECRETION OF PIGMENTED EPITHELIUM DERIVED FACTOR: TGF-beta RECEPTOR INHIBITORS AS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF SCLERODERMA. In: 37th SEF National Meeting with guest society: the British Pharmacology Society, 18-21 Jun 2017, Barcelona, Spain.

Elpidorou, M, Best, S, Poulter, JA orcid.org/0000-0003-2048-5693 et al. (4 more authors) (2020) Novel loss-of-function mutation in HERC2 is associated with severe developmental delay and paediatric lethality. Journal of Medical Genetics. ISSN 0022-2593

Elshimy, N, Rajib, R, Mitra, A et al. (4 more authors) (2020) A challenging case of Stevens-Johnson syndrome. In: 15th Medical Dermatology Meeting, Royal College of Physicians, 09 Jan 2020, London, UK.

Emery, P orcid.org/0000-0002-7429-8482 and Duquenne, L (2020) It's never too soon to treat rheumatoid arthritis: finally, some supportive evidence. The Lancet Rheumatology, 2 (6). E311-E313. ISSN 2665-9913

Emery, P, Mankia, K and Nam, JL (2017) Individuals at risk of rheumatoid arthritis – The evolving story. Best Practice & Research Clinical Rheumatology, 31 (1). pp. 1-2. ISSN 1521-6942

Emery, P orcid.org/0000-0002-7429-8482, Vlahos, B, Szczypa, P et al. (9 more authors) (2020) Longterm Drug Survival of Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis. The Journal of Rheumatology, 47 (4). pp. 493-501. ISSN 0315-162X

Emery, P, Blanco, R, Maldonado Cocco, J et al. (8 more authors) (2017) Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis. RMD Open, 3 (1). e000410. ISSN 2056-5933

Emery, P orcid.org/0000-0002-7429-8482, Breedveld, F, Campos-Alberto, E et al. (2 more authors) (2021) Clinical, Radiologic, and Functional Outcomes Following Methotrexate Withdrawal in Etanercept-Treated Patients with Active Early Rheumatoid Arthritis: A Subanalysis of COMET Year 2 by Week 52 DAS28 Status. Open Rheumatology Journal, 15. pp. 31-38. ISSN 1874-3129

Emery, P orcid.org/0000-0002-7429-8482, Burmester, GR, Bykerk, VP et al. (4 more authors) (2019) Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study. RMD Open, 5 (1). e000840. ISSN 2056-5933

Emery, P orcid.org/0000-0002-7429-8482, Burmester, GR, Naredo, E et al. (4 more authors) (2020) Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study. Annals of the Rheumatic Diseases. ISSN 0003-4967

Emery, P orcid.org/0000-0002-7429-8482, Durez, P, Hueber, AJ et al. (4 more authors) (2021) Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis – a comprehensive review. Arthritis Research and Therapy, 23 (3). ISSN 1478-6354

Emery, P orcid.org/0000-0002-7429-8482, Furst, DE, Kirchner, P et al. (3 more authors) (2020) Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data. Rheumatology and Therapy, 7. pp. 121-131. ISSN 2198-6584

Emery, P orcid.org/0000-0002-7429-8482, Horton, S, Dumitru, RB et al. (5 more authors) (2020) Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. Annals of the Rheumatic Diseases, 79 (4). pp. 464-471. ISSN 0003-4967

Emery, P, Pope, JE, Kruger, K et al. (4 more authors) (2018) Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review. Advances in Therapy, 35 (10). pp. 1535-1563. ISSN 0741-238X

Emery, P orcid.org/0000-0002-7429-8482, Rondon, J, Parrino, J et al. (8 more authors) (2019) Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis. Rheumatology, 58 (5). pp. 849-858. ISSN 1462-0324

Emery, P orcid.org/0000-0002-7429-8482, Tanaka, Y, Cardillo, T et al. (5 more authors) (2020) Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22 (1). 166. 166-. ISSN 1478-6354

Emery, P orcid.org/0000-0002-7429-8482, Tanaka, Y, Cardillo, T et al. (5 more authors) (2020) Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis. Arthritis Research & Therapy, 22 (1). 115. ISSN 1478-6354

Emery, P orcid.org/0000-0002-7429-8482, Van Keep, M, Beard, S et al. (6 more authors) (2018) Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK. PharmacoEconomics, 36 (8). pp. 1015-1027. ISSN 1170-7690

Emery, P orcid.org/0000-0002-7429-8482, van Hoogstraten, H, Thangavelu, K et al. (3 more authors) (2020) Subcutaneous Sarilumab in Patients with Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open-Label Extension of a Randomized Clinical Trial. ACR Open Rheumatology, 2 (11). pp. 672-680. ISSN 2578-5745

F

Farrow, M, Grainger, AJ, Tan, AL orcid.org/0000-0002-9158-7243 et al. (6 more authors) (2019) Normal values and test–retest variability of stimulated-echo diffusion tensor imaging and fat fraction measurements in the muscle. British Journal of Radiology, 92 (1101). 20190143. ISSN 0007-1285

Farrow, M, Biglands, J orcid.org/0000-0002-1161-5022, Tanner, SF et al. (6 more authors) (2021) The effect of ageing on skeletal muscle as assessed by quantitative MR imaging: an association with frailty and muscle strength. Aging Clinical and Experimental Research, 33 (2). pp. 291-301. ISSN 1594-0667

Farrow, M, Biglands, J orcid.org/0000-0002-1161-5022, Tanner, SF et al. (4 more authors) (2020) Muscle deterioration due to rheumatoid arthritis: Assessment by quantitative MRI and strength testing. Rheumatology. keaa364. ISSN 1462-0324

Farrow, M, Biglands, JD orcid.org/0000-0002-1161-5022, Grainger, AJ et al. (6 more authors) (2021) Quantitative MRI in myositis patients: comparison with healthy volunteers and radiological visual assessment. Clinical Radiology, 76 (1). 81 e.1-81 e.10. ISSN 0009-9260

Fautrel, B., Mitrovic, S., De Matteis, A. et al. (30 more authors) (2024) EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still’s disease. Annals of the Rheumatic Diseases, 83 (12). pp. 1614-1627. ISSN 0003-4967

Fautrel, B, Zhu, B, Taylor, PC et al. (8 more authors) (2020) Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab, and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison. RMD Open, 6. e001131. ISSN 2056-5933

Feher, A., Del Galdo, F. orcid.org/0000-0002-8528-2283 and Plein, S. orcid.org/0000-0002-0997-4384 (2024) Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI. Current Opinion in Rheumatology, 36 (6). pp. 387-392. ISSN 1040-8711

Fent, G, Mankia, K, Erhayiem, B et al. (10 more authors) (2019) First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis. Annals of the Rheumatic Diseases, 78 (8). pp. 1138-1140. ISSN 0003-4967

Ferrada, M, Savic, S, Alessi, H et al. (18 more authors) (2021) Genotype and Transfusion Dependence Predicts Mortality in VEXAS Syndrome, a Newly Described Disease with Overlap Inflammatory and Hematologic Features. In: ACR Convergence 2021, 05-09 Nov 2021, Virtual.

Ferrada, M, Sikora, K, Lou, Y et al. (14 more authors) (2021) Classification of Patients with Relapsing Polychondritis Based on Somatic Mutations in UBA1. In: EULAR 2021, 02-05 Jun 2021, Virtual.

Ferrada, M, Sikora, K, Savic, S orcid.org/0000-0001-7910-0554 et al. (15 more authors) (2020) Classification of Patients with Relapsing Polychondritis Based on Somatic Mutations in UBA1. In: ACR Convergence 2020, 05-09 Nov 2020, Online.

Ferrada, MA, Savic, S orcid.org/0000-0001-7910-0554, Ospina Cardona, D et al. (29 more authors) (2022) Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood, 140 (13). pp. 1496-1506. ISSN 0006-4971

Ferrada, MA, Sikora, KA, Luo, Y et al. (32 more authors) (2021) Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS. Arthritis and Rheumatology, 73 (10). pp. 1886-1895. ISSN 2326-5191

Fisher, BA, Emery, P orcid.org/0000-0002-7429-8482, Pitzalis, C et al. (2 more authors) (2019) Response to: Can ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren’s syndrome? Annals of the Rheumatic Diseases, 78 (4). e28-e28. ISSN 0003-4967

Fitton, J orcid.org/0000-0002-7795-8191, Melville, AR, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway. Rheumatology. ISSN 1462-0324

Freeston, JE orcid.org/0000-0003-0358-338X, Coates, LC orcid.org/0000-0002-4756-663X, Helliwell, PS et al. (4 more authors) (2010) Is There Sub-Clinical Joint Disease in Early Psoriatic Arthritis? A Clinical Comparison with Power Doppler Ultrasound. In: Rheumatology. Annual Meeting of the British Society of Rheumatology, 21-23 Apr 2010, Birmingham, UK. Oxford University Press .

Freeston, J. orcid.org/0000-0003-0358-338X, Marzetti, M., Larkman, N. et al. (3 more authors) (2024) Whole-body MRI for the investigation of joint involvement in inflammatory arthritis. Skeletal Radiology, 53 (5). pp. 935-945. ISSN 0364-2348

Furer, V, Kishimoto, M, Tsuji, S et al. (5 more authors) (2020) The Diagnosis and Treatment of Adult Patients with SAPHO Syndrome: Controversies Revealed in a Multidisciplinary International Survey of Physicians. Rheumatology and Therapy, 7 (4). pp. 883-891. ISSN 2198-6584

G

Galdo, F.D. and Matucci-Cerinic, M. (2020) A special European Journal of Rheumatology issue on systemic sclerosis: What and why? European Journal of Rheumatology, 7 (Supplement 3). S137-S138. ISSN 2147-9720

Ganguly, P, El-Jawhari, JJ orcid.org/0000-0002-0580-4492, Giannoudis, PV orcid.org/0000-0002-5205-7696 et al. (3 more authors) (2017) Age-related Changes in Bone Marrow Mesenchymal Stromal Cells: A Potential Impact on Osteoporosis and Osteoarthritis Development. Cell Transplantation, 26 (9). pp. 1520-1529. ISSN 0963-6897

Ganguly, P, J-El-Jawhari, J, Burska, AN et al. (3 more authors) (2019) The Analysis of In Vivo Aging in Human Bone Marrow Mesenchymal Stromal Cells Using Colony-Forming Unit-Fibroblast Assay and the CD45lowCD271+ Phenotype. Stem Cells International. 5197983. ISSN 1687-966X

Garaiman, A., Steigmiller, K., Gebhard, C. et al. (171 more authors) (2023) Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology, 62 (SI). SI91-SI100. ISSN 1462-0324

Garcia-Montoya, L, Villota-Eraso, C, Yusof, MYM et al. (2 more authors) (2020) Lessons for rituximab therapy in patients with rheumatoid arthritis. The Lancet Rheumatology. ISSN 2665-9913

Garcia-Montoya, L., Kang, J., Duquenne, L. et al. (6 more authors) (2024) Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study. The Lancet Rheumatology, 6 (2). e72-e80. ISSN 2665-9913

Garcia-Montoya, L and Emery, P orcid.org/0000-0002-7429-8482 (2021) Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials. Expert Opinion on Investigational Drugs, 30 (11). pp. 1109-1124. ISSN 1354-3784

Garcia-Montoya, L, Gul, H and Emery, P (2018) Recent advances in ankylosing spondylitis: understanding the disease and management. F1000Research, 7.

Garcia-Montoya, L, Nam, JL, Duquenne, L et al. (5 more authors) (2022) Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study. Arthritis Research and Therapy, 24. 26. ISSN 1478-6354

Gillespie, J, Ross, RL, Corinaldesi, C et al. (7 more authors) (2018) Transforming Growth Factor β Activation Primes Canonical Wnt Signaling Through Down-Regulation of Axin-2. Arthritis & Rheumatology, 70 (6). pp. 932-942. ISSN 2326-5191

Giollo, A, Gandrala, S, Vojinovic, T et al. (5 more authors) (2018) THU0136 Major cardiovascular events in 434 rheumatoid arthritispatients treated with rituximab from a single-centre. In: Annual European Congress of Rheumatology, EULAR 2018, 13-16 Jun 2018, Amsterdam, Netherlands.

Gjeloshi, K., Danzo, F., Abignano, G. et al. (4 more authors) (2020) P150 Influence of patient reported arthritis activity in determining sHAQ, HAQ-DI and Cochin scores in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2020. Oxford University Press .

Gjeloshi, K., Danzo, F., Lettieri, G. et al. (6 more authors) (2020) O32 Digital artery volume index (DAVIX©) predicts the onset of future digital ulcers in patients with SSc. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press , p. 15.

Gladman, D, Boehncke, W-H, Gottlieb, AB et al. (7 more authors) (2019) The Effect of Guselkumab on Dactylitis: Results from a Phase 2 Study in Patients with Active Psoriatic Arthritis. In: Pan-American Congress of Rheumatology 2019, 27-30 Apr 2019, Quito, Ecuador.

Gladman, D, Coates, L, Wu, J et al. (6 more authors) (2019) Time to Response for Clinical and Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Tofacitinib, Adalimumab, or Placebo. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Gladman, DD, Coates, LC, Van den Bosch, F et al. (9 more authors) (2020) FRI0339 LONG-TERM EFFICACY OF THE ORAL SELECTIVE JANUS KINASE 1 INHIBITOR FILGOTINIB IN PSORIATIC ARTHRITIS: WEEK 52 RESPONSE PATTERNS IN INDIVIDUAL PATIENTS FROM AN OPEN-LABEL EXTENSION (OLE) STUDY (EQUATOR2). In: EULAR 2020, 03-06 Jun 2020, Online.

Gladman, D.D., Mease, P.J., Bird, P. et al. (13 more authors) (2022) AB0894 Efficacy and Safety of Guselkumab in Biologic-Naïve Patients With Active Axial Psoriatic Arthritis: Study Design of a Phase 4, Randomized, Double-Blind, Placebo-Controlled Trial. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 1574-1575.

Gladman, DD, Mease, PJ, Bird, P et al. (14 more authors) (2022) Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial. Trials, 23 (1). 743. ISSN 1745-6215

Goel, N, FitzGerald, O, Gladman, DD et al. (6 more authors) (2019) GRAPPA 2018 Project Report. The Journal of Rheumatology Supplement, 95. pp. 54-57. ISSN 0380-0903

Goel, N, Coates, LC orcid.org/0000-0002-4756-663X, De Marco, G orcid.org/0000-0003-2406-161X et al. (11 more authors) (2020) GRAPPA 2019 Project Report. The Journal of Rheumatology Supplement, 96. pp. 53-57. ISSN 0380-0903

Gossec, L, Kirkham, B, Rahman, P et al. (4 more authors) (2018) Clinically Meaningful Improvement in Health-Related Quality of Life and the Association with Disease Activity in Psoriatic Arthritis after Treatment with Guselkumab: Results from a Randomized Placebo-Controlled Phase II Clinical Trial. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Griffiths-Jones, D.J., Garcia, Y.S., Ryder, W.D. et al. (19 more authors) (2023) A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS). Rheumatology, 62 (9). pp. 3133-3138. ISSN 1462-0324

Gul, HL, Eugenio, G, Rabin, T et al. (5 more authors) (2020) Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes. Rheumatology, 59 (3). kez330. pp. 613-621. ISSN 1462-0324

Gul, H. orcid.org/0000-0003-2546-8614, Di Matteo, A. orcid.org/0000-0003-0867-7051, Anioke, I. orcid.org/0000-0001-7600-4823 et al. (4 more authors) (2024) Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy. ACR Open Rheumatology, 6 (5). pp. 294-303. ISSN 2578-5745

Gul, HL, Di Matteo, A, Mankia, K et al. (3 more authors) (2022) Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission? Clinical and Experimental Rheumatology. CER15516. ISSN 1593-098X

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic Hematopoietic Cell Transplantation for Vexas Syndrome: Results of a Multicenter Study from the Chronic Malignancies and Autoimmune Disease Working Parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , pp. 708-710.

H

Hackett, KL, Davies, K, Tarn, J et al. (32 more authors) (2019) Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sjögren's syndrome. RMD Open, 5 (1). e000885. ISSN 2056-5933

Hailey, L., Bundy, C., Burstow, H. et al. (13 more authors) (2023) The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership. Rheumatology, 62 (8). pp. 2716-2723. ISSN 1462-0324

Hailey, L. orcid.org/0000-0001-5769-8663, Bundy, C., Burstow, H. et al. (13 more authors) (2022) The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership. Rheumatology, 62 (8). pp. 2716-2723. ISSN 1462-0324

Hamann, PDH, Pauling, JD, McHugh, N et al. (3 more authors) (2019) Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients. Rheumatology, 58 (12). pp. 2162-2169. ISSN 1462-0324

Han, MK, Antila, M, Ficker, JH et al. (17 more authors) (2022) Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet Rheumatology, 4 (5). e351-e361. ISSN 2665-9913

Harrison, S.R., Aung Din, B.N.R., Marzo‑Ortega, H. et al. (1 more author) (2024) Recent advances in the management of psoriatic arthritis: practical considerations. Polish Archives of Internal Medicine, 134 (1). 16639. ISSN 0032-3772

Harrison, S.R. orcid.org/0000-0002-7465-2621, Campbell, F., Bennett, H. et al. (10 more authors) (2024) High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study. British Journal of Dermatology. ljae292. ISSN 0007-0963

Hassan, SU, Md Yusof, MY, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Biologic Sequencing in Systemic Lupus Erythematosus: After Secondary Non-response to Rituximab, Switching to Humanised Anti-CD20 Agent Is More Effective Than Belimumab. Frontiers in Medicine, 7. 498. ISSN 2296-858X

Helliwell, P, Bushmakin, A, Gladman, D et al. (5 more authors) (2019) Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Helliwell, P, Coates, LC, FitzGerald, O et al. (8 more authors) (2018) Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis. In: Pan-American League of Rheumatology Associations (PANLAR) Congress 2018, 07-10 Apr 2018, Buenos Aires, Argentina.

Helliwell, P, Deodhar, A, Gottlieb, AB et al. (7 more authors) (2019) Comparing Composite Measures of Disease Activity in Psoriatic Arthritis: Results From a Randomized Phase 2 Trial with Guselkumab. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 1843.

Helliwell, P, Gladman, DD, Poddubnyy, D et al. (13 more authors) (2020) OP0054 EFFICACY OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF IL-23, ON ENDPOINTS RELATED TO AXIAL INVOLVEMENT IN PATIENTS WITH ACTIVE PSA WITH IMAGING-CONFIRMED SACROILIITIS: WEEK-24 RESULTS FROM TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES. In: EULAR 2020, 03-06 Jun 2020, Online.

Helliwell, P, Gottlieb, AB, Deodhar, A et al. (7 more authors) (2019) The Effect of Guselkumab on Enthesitis: Results from a Phase 2 Study in Patients with Active Psoriatic Arthritis. In: Pan-American Congress of Rheumatology 2019, 27-30 Apr 2019, Quito, Ecuador.

Helliwell, P, Lespessailles, E, Shuler, CL et al. (4 more authors) (2018) Ixekizumab Provides Sustained Improvement In Signs And Symptoms In Patients With Active Psoriatic Arthritis: Two Year Results From A Phase 3 Trial. In: 20th PANLAR Meeting, 07-10 Apr 2018, Buenos Aires, Argentina.

Helliwell, P, Rahman, P, Deodhar, A et al. (6 more authors) (2020) SAT0421 GUSELKUMAB DEMONSTRATED AN INDEPENDENT TREATMENT EFFECT ON FATIGUE AFTER ADJUSTMENT FOR CLINICAL RESPONSE (ACR20) IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM PHASE-3 TRIALS DISCOVER 1 & 2. In: EULAR 2020, 03-06 Jun 2020, Online.

Helliwell, P, Tillett, W, Waxman, R et al. (4 more authors) (2020) AB1241 EVALUATION OF A PATIENT COMPLETED DISEASE FLARE QUESTIONNAIRE IN PSORIATIC DISEASE. In: EULAR 2020, 03-06 Jun 2020, Online.

Helliwell, P, Van den Bosch, F, Coates, LC et al. (9 more authors) (2020) FRI0343 EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR). In: EULAR 2020, 03-06 Jun 2020, Online.

Helliwell, PS, Coates, LC orcid.org/0000-0002-4756-663X, Chew, NS et al. (7 more authors) (2020) Comparing Psoriatic Arthritis Low-field Magnetic Resonance Imaging, Ultrasound, and Clinical Outcomes: Data from the TICOPA Trial. Journal of Rheumatology, 47 (9). 181385. pp. 1338-1343. ISSN 0315-162X

Helliwell, PS, Favier, G, Gladman, DD et al. (6 more authors) (2019) Best-practice Indicators in Psoriatic Disease Care. The Journal of Rheumatology Supplement, 95. pp. 38-45. ISSN 0380-0903

Helliwell, P orcid.org/0000-0002-4155-9105, Coates, LC, Van den Bosch, F et al. (7 more authors) (2021) The Effect of Filgotinib on Enthesitis: 100-Week Data from an Open-Label Extension Study in Patients with Active Psoriatic Arthritis. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Helliwell, P orcid.org/0000-0002-4155-9105, Mease, P, Kavanaugh, A et al. (9 more authors) (2020) What Influence Do Clinical Domains Other Than Arthritis Have on Composite Clinical Outcomes in Psoriatic Arthritis?: Comparison of Treatment Effects in the SEAM-PsA Trial. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Helliwell, PS (2020) Axial disease in psoriatic arthritis. Rheumatology, 59 (6). pp. 1193-1195. ISSN 1462-0324

Hemgren, C., Martinsson, K., Rooney, C. et al. (4 more authors) (2024) Elevated Serum Levels of Zonulin Family Peptides in Anticitrullinated Protein Antibody–Positive At-Risk Individuals Without Arthritis. The Journal of Rheumatology, 51 (2). pp. 134-138. ISSN 0315-162X

Hen, O., Di Matteo, A., Dubash, S.R. et al. (7 more authors) (2024) High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort. RMD Open, 10 (2). e003841. ISSN 2056-5933

Hensor, EMA orcid.org/0000-0002-5245-4755, McKeigue, P, Buch, MH orcid.org/0000-0002-8962-5642 et al. (20 more authors) (2018) Validity of a2-component imaging-derived disease activity score (2C-DAS28) for improved assessment of synovitis in early rheumatoid arthritis. In: Rheumatology. British Society for Rheumatology Annual Conference 2018, 01-03 May 2018, Liverpool, United Kingdom. Oxford University Press .

Hensor, E., Lazzaroni, M.G., Wilson, M. et al. (2 more authors) (2023) Pitfalls when estimating causal effects in observational data: a simulation study based on the eustar database. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 991-992.

Hensor, EMA orcid.org/0000-0002-5245-4755, McKeigue, P, Ling, SF et al. (20 more authors) (2019) Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis. Rheumatology, 58 (8). pp. 1400-1409. ISSN 1462-0324

Hinks, A, Ke, X, Barton, A et al. (9 more authors) (2009) Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis & Rheumatism, 60 (1). pp. 251-257. ISSN 0004-3591

Hoffmann-Vold, A.-M., Allanore, Y., Alves, M. et al. (87 more authors) (2021) Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Annals of the Rheumatic Diseases, 80 (2). pp. 219-227. ISSN 0003-4967

Howard Tripp, N, Tarn, J, Natasari, A et al. (29 more authors) (2016) Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines. RMD Open, 2 (2). e000282.

Hughes, M., Allanore, Y., Baron, M. et al. (13 more authors) (2022) Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. The Lancet Rheumatology, 4 (11). e795-e803. ISSN 2665-9913

Hughes, M. orcid.org/0000-0003-3361-4909, Di Donato, S. orcid.org/0000-0003-1256-0761, Gjeloshi, K. et al. (9 more authors) (2023) MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study. The Lancet Rheumatology, 5 (10). e611-e621. ISSN 2665-9913

Hughes, M., Di Donato, S., Gjeloshi, K. et al. (9 more authors) (2023) MRI digital artery volume index (DAVIX©) as quantitative, continuous imaging outcome measure of vascular disease in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 1018.

Hughes, M., Huang, S., Alegre-Sancho, J.J. et al. (98 more authors) (2023) Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology, 62 (SI). SI54-SI63. ISSN 1462-0324

Hurnakova, J, Filippucci, E, Cipolletta, E et al. (11 more authors) (2019) Prevalence and distribution of cartilage damage at the metacarpal head level in rheumatoid arthritis and osteoarthritis: an ultrasound study. Rheumatology, 58 (7). pp. 1206-1213. ISSN 1462-0324

Husni, ME, Gladman, DD, Helliwell, P et al. (9 more authors) (2020) FRI0344 THE LONG-TERM EFFECT OF TREATING PSORIATIC ARTHRITIS WITH THE JANUS KINASE 1-SELECTIVE INHIBITOR FILGOTINIB ON LIPID PROFILES: AN ANALYSIS OF THE EQUATOR AND EQUATOR2 TRIALS. In: EULAR 2020, 03-06 Jun 2020, Online.

Hägele, P., Staus, P., Scheible, R. et al. (146 more authors) (2024) Diagnostic evaluation of paediatric autoimmune lymphoproliferative immunodeficiencies (ALPID): a prospective cohort study. The Lancet Haematology, 11 (2). e114-e126. ISSN 2451-9960

I

Ibrahim, S.T., Rhodes, B., Griffiths, B. et al. (9 more authors) (2024) Differences in Management Approaches for Lupus Nephritis within the UK. Rheumatology Advances in Practice, 8 (1). rkae017. ISSN 1462-0324

Inomata, H, Bissell, L-A orcid.org/0000-0002-2789-4652, Naraghi, K et al. (6 more authors) (2016) FRI0130 Efficacy of A Comprehensive Cardiovascular Risk Reduction Patient Education Programme in Patients with Early Inflammatory Arthritis Following A Treat To Target Therapeutic Regime. In: Annals of the Rheumatic Diseases. EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 475.

J

Jacobs, J., Maurer, M., Gimenez-Arnau, A. et al. (5 more authors) (2023) REMIBRUTINIB PROVIDES FAST AND CLINICALLY IMPORTANT IMPROVEMENT OF CHRONIC SPONTANEOUS URTICARIA DISEASE ACTIVITY. In: Annals of Allergy, Asthma & Immunology. 2023 Annual Scientific Meeting - American College of Allergy, Asthma & Immunology, 09-13 Nov 2023, Anaheim, USA. Elsevier , S34-S35.

Jadon, DR, Chandran, V, Ogdie, A et al. (12 more authors) (2019) Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology Supplement, 95. pp. 11-19. ISSN 0380-0903

Jani, M, Dixon, WG, Kersley-Fleet, L et al. (7 more authors) (2017) Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD Open, 3 (1). e000314. ISSN 2056-5933

Jani, M, Isaacs, JD, Morgan, AW orcid.org/0000-0003-1109-624X et al. (5 more authors) (2017) High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort. Annals of the Rheumatic Diseases, 76 (1). pp. 208-213. ISSN 0003-4967

Jarosz-Griffiths, H.H., Caley, L.R., Lara-Reyna, S. et al. (4 more authors) (2023) EPS3.08 Heightened mitochondrial respiration and succinate levels in cystic fibrosis cells is normalised with triple CFTR modulator therapy through mechanisms involving cell calcium flux. In: Journal of Cystic Fibrosis. European Cystic Fibrosis Conference 2023, 07-10 Jun 2023, Vienna, Austria. Elsevier , s45-s45.

Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Caley, L.R. orcid.org/0000-0001-8957-1018, Lara-Reyna, S. et al. (4 more authors) (2024) Heightened mitochondrial respiration in CF cells is normalised by triple CFTR modulator therapy through mechanisms involving calcium. Heliyon, 10 (20). e39244. ISSN 1879-4378

Jarosz-Griffiths, H.H. orcid.org/0000-0001-5154-4815, Gillgrass, L., Caley, L.R. orcid.org/0000-0001-8957-1018 et al. (6 more authors) (2024) Anti-inflammatory effects of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis heterozygous for F508del. PLOS ONE, 19 (5). e0304555. ISSN 1932-6203

Jarosz-Griffiths, HH orcid.org/0000-0001-5154-4815, Scambler, T, Wong, CH orcid.org/0000-0003-2108-1615 et al. (11 more authors) (2020) Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis. eLife, 9. e54556. ISSN 2050-084X

John, A.J.U.K. orcid.org/0000-0003-3080-7393, Del Galdo, F. orcid.org/0000-0002-8528-2283, Gush, R. orcid.org/0000-0002-8624-3606 et al. (1 more author) (2023) An evaluation of mechanical and biophysical skin parameters at different body locations. Skin Research and Technology, 29 (2). e13292. ISSN 0909-752X

K

Kacar, M, Cortes-Acevedo, P, Patel, V et al. (8 more authors) (2021) Neutralizing Anti-interferon-γ Autoantibodies: an Ameliorating Factor in COVID-19 Infection? Journal of Clinical Immunology, 41. pp. 1531-1535. ISSN 0271-9142

Kacar, M, Fitton, J orcid.org/0000-0002-7795-8191, Gough, AK et al. (3 more authors) (2020) Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease. RMD Open, 6 (2). e001246. ISSN 2056-5933

Kakkar, V., Assassi, S., Allanore, Y. et al. (4 more authors) (2022) Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit. Current Opinion in Rheumatology, 34 (6). pp. 357-364. ISSN 1040-8711

Kakkar, V, Ross, R, Karanth, R et al. (8 more authors) (2021) Immunogenicity of a Single Dose of Covid-19 Vaccination in Patients with Systemic Sclerosis with or Without Immunosupression. In: ACR Convergence 2021, 05-09 Nov 2021, Virtual.

Kamal, K., Xia, E., Li, S.J. et al. (21 more authors) (2024) Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group. Journal of Investigative Dermatology, 144 (6). 1295-1300.e6. ISSN 0022-202X

Karadag, D.T., Lettieri, G., Picerno, V. et al. (7 more authors) (2020) P162 Cross-validation and complementary value of optical coherence tomography and high frequency ultrasound for the assessment of skin disease in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press , ii78.

Kavanaugh, A, Helliwell, P orcid.org/0000-0002-4155-9105, Sesin, C et al. (6 more authors) (2021) Low Disease Thresholds up to Three Years in Ixekizumab-Treated Patients with Psoriatic Arthritis in SPIRIT-P1 and SPIRIT-P2. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Kavanaugh, A, Liu, Y, Deodhar, A et al. (8 more authors) (2021) Correlations Between Reductions in Fatigue Severity and Improvements in Physical Function and Clinical Response in Patients with Psoriatic Arthritis: Results from the Phase 3 Discover Program. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Kavanaugh, A, Liu, Y, Deodhar, A et al. (8 more authors) (2021) Correlations Between Reductions in Fatigue Severity and Improvements in Physical Function and Clinical Response in Patients with Psoriatic Arthritis: Results from the Phase 3 DISCOVER Program. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Kay, J, Dörner, T, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2020) Clinical trial and ‘real-world’ data support switching from a bio-originator to its biosimilar. Annals of the Rheumatic Diseases, 79 (4). e44. ISSN 0003-4967

Kelly, C, Emery, P orcid.org/0000-0002-7429-8482 and Dieudé, P (2021) Current issues in rheumatoid arthritis associated interstitial lung disease. The Lancet Rheumatology, 3 (11). E798-E807. ISSN 2665-9913

Khanna, D., Denton, C.P., Assassi, S. et al. (12 more authors) (2024) A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale. Clinical and Experimental Rheumatology, 42 (8). pp. 1635-1644. ISSN 0392-856X

Khoja, O., Silva-Passadouro, B., Cristescu, E. et al. (8 more authors) (2024) Clinical Characterization of New-Onset Chronic Musculoskeletal Pain in Long COVID: A Cross-Sectional Study. Journal of Pain Research, 17. pp. 2531-2550. ISSN 1178-7090

Kim, HU, Alten, R, Cummings, F et al. (14 more authors) (2021) Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs, 13 (1). 1868078. ISSN 1942-0862

Kitas, GD, Nightingale, P, Armitage, J et al. (4 more authors) (2019) A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis. Arthritis and Rheumatology, 71 (9). pp. 1437-1449. ISSN 2326-5191

Klotsche, J., Foeldvari, I., Torok, K. et al. (37 more authors) (2023) POS0141 Application Of Criss Score, Revised Criss Score And RCID Score In Patients With Juvenile Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 290-291.

Kondo, M., Suzuki, T., Kawano, Y. et al. (10 more authors) (2022) Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis. Arthritis Research & Therapy, 24. 210. ISSN 0003-4967

Kreuter, M. orcid.org/0000-0003-4402-2159, Del Galdo, F. orcid.org/0000-0002-8528-2283, Miede, C. et al. (7 more authors) (2022) Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis. Arthritis Research & Therapy, 24. 19. ISSN 1478-6354

Kumavat, R, Kumar, V, Malhotra, R et al. (4 more authors) (2021) Biomarkers of Joint Damage in Osteoarthritis: Current Status and Future Directions. Mediators of Inflammation, 2021. 5574582. pp. 1-15. ISSN 0962-9351

Kuster, S., Jordan, S., Elhai, M. et al. (104 more authors) (2022) Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open, 8 (2). e002477. ISSN 2056-5933

L

Lachmann, H, Lauwerys, B, Miettunen, P et al. (9 more authors) (2019) Canakinumab Improves Patient-Reported Outcomes in Patients with Recurrent Fever Syndromes: Results from a Phase 3 Trial. In: 2019 ACR/ARP Annual Meeting.

Lachmann, HJ, Lauwerys, B, Miettunen, P et al. (9 more authors) (2021) Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial. Clinical and Experimental Rheumatology, 39 (5, Suppl.132). S-51-S-58. ISSN 0392-856X

Lamana, A, Villares, R, Seoane, IV et al. (14 more authors) (2020) Identification of a Human SOCS1 Polymorphism That Predicts Rheumatoid Arthritis Severity. Frontiers in Immunology, 11. 1336. ISSN 1664-3224

Lara-Reyna, S, Poulter, JA orcid.org/0000-0003-2048-5693, Vasconcelos, EJR orcid.org/0000-0001-5130-6622 et al. (5 more authors) (2021) Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease. Journal of Clinical Immunology, 41 (2). pp. 441-457. ISSN 0271-9142

Lawless, D, Allen, HL, Thaventhiran, JED et al. (7 more authors) (2023) Prevalence of CFTR variants in PID patients with bronchiectasis - an important modifying co-factor. Journal of Allergy and Clinical Immunology, 152 (1). pp. 257-265. ISSN 0091-6749

Lawless, D orcid.org/0000-0001-8496-3725, Lango Allen, H, Thaventhiran, J et al. (6 more authors) (2019) Predicting the Occurrence of Variants in RAG1 and RAG2. Journal of Clinical Immunology, 39 (7). pp. 688-701. ISSN 0271-9142

Lazzaroni, M-G., Marasco, E., Campochiaro, C. et al. (30 more authors) (2021) The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort. Rheumatology, 60 (11). pp. 5028-5041. ISSN 1462-0324

Lazzaroni, M.G., Wilson, M., Hensor, E. orcid.org/0000-0002-5245-4755 et al. (15 more authors) (2022) POS0893 Factors to consider for measuring the effect of lung function on patient reported outcomes in Systemic Sclerosis patients: Analysis of the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 743-744.

Lee, C., Greenwood, D.C. orcid.org/0000-0001-7035-3096, Master, H. et al. (13 more authors) (2023) Prevalence of orthostatic intolerance in Long Covid clinic patients: A multicentre observational study. [Preprint]

Lee, P., Green, L., Marzec, B. et al. (3 more authors) (2024) Dystrophic calcinosis: structural and morphological composition, and evaluation of ethylenediaminetetraacetic acid (‘EDTA’) for potential local treatment. Arthritis Research and Therapy, 26. 102. ISSN 1478-6354

Lefteri, DA orcid.org/0000-0002-9985-4254, Bryden, SR orcid.org/0000-0001-5408-6047, Pingen, M orcid.org/0000-0001-5689-9076 et al. (15 more authors) (2022) Mosquito saliva enhances virus infection through sialokinin-dependent vascular leakage. Proceedings of the National Academy of Sciences (PNAS), 119 (24). e2114309119. ISSN 0027-8424

Lepri, G., Bruni, C. orcid.org/0000-0003-2813-2083, Tofani, L. orcid.org/0000-0001-9965-7667 et al. (23 more authors) (2024) The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database. Diagnostics, 14 (3). ARTN 295. ISSN 2075-4418

Lepri, G., Hughes, M., Allanore, Y. et al. (8 more authors) (2023) The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution. The Lancet Rheumatology, 5 (7). e422-e425. ISSN 2665-9913

Lescoat, A., Bellando-Randone, S., Campochiaro, C. et al. (9 more authors) (2023) Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine. The Lancet Rheumatology, 5 (11). e683-e694. ISSN 2665-9913

Lescoat, A., Bertoldo, E., Colic, J. et al. (6 more authors) (2023) Systematic literature review for the 2023 update of eular recommendations for the treatment of systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 973.

Lescoat, A., Bertoldo, E., Čolić, J. et al. (6 more authors) (2024) Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Lescoat, A., Chen, Y., Murphy, S.L. et al. (22 more authors) (2023) POS1258 Results from a nominal group technique exercise for the creation of a combined response index for limited cutaneous systemic sclerosis: The CRISTAL project. In: Annals of the Rheumatic Diseases. EULAR 2023 - European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 971-972.

Lescoat, A., Huang, S., Carreira, P.E. et al. (219 more authors) (2023) Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatology, 159 (8). pp. 837-847. ISSN 2168-6068

Lescoat, A., Murphy, S.L., Chen, Y.T. et al. (5 more authors) (2022) Symptom experience of limited cutaneous systemic sclerosis from the Patients’ perspective: A qualitative study. Seminars in Arthritis and Rheumatism, 52. 151926. ISSN 0049-0172

Lescoat, A., Murphy, S.L., Roofeh, D. et al. (17 more authors) (2020) Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. Journal of Scleroderma and Related Disorders, 6 (1). 66 -76. ISSN 2397-1983

Liakouli, V. orcid.org/0000-0002-7392-9334, Ciancio, A., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (2 more authors) (2024) Systemic sclerosis interstitial lung disease: unmet needs and potential solutions. Nature Reviews Rheumatology, 20 (1). pp. 21-32. ISSN 1759-4790

Littlejohns, A., Arumugakani, G., Mistry, A. et al. (5 more authors) (2023) Diagnostic certainty in perioperative anaphylaxis. In: Clinical & Experimental Allergy. BSACI Annual Conference 2023, 05-07 Oct 2023, Harrogate, UK. Wiley , p. 1074.

Littlejohns, A., Hopkins, P., Savic, S. orcid.org/0000-0001-7910-0554 et al. (3 more authors) (2023) The burden of perioperative teicoplanin allergy in Yorkshire 2013-22. In: British Journal of Anaesthesia. Anaesthetic Research Society Spring Meeting, 20-21 Jun 2023, Manchester, UK. Elsevier , E96.

Longhurst, H.J., Smith, M.D., Yea, C. et al. (1 more author) (2022) SEBETRALSTAT EFFECTIVENESS IN THE TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS RATED MILD OR MODERATE AT BASELINE IN THE PHASE 2 TRIAL. In: INTERNAL MEDICINE JOURNAL. 32nd Annual Conference of the Australasian Society of Clinical Immunology and Allergy (ASCIA), 30 Aug - 02 Sep 2022, Melbourne, Australia. , p. 29.

Lovatt, J, Lam, S, Carter, C et al. (8 more authors) (2021) T cell response in immunosuppressed redo-liver transplant recipients after COVID-19 infection and after first dose of vaccine against SARS-CoV-2. In: The 2021 Virtual International Congress of ILTS, ELITA and LICAGE, 05-08 May 2021, Virtual.

M

Maccari, M.E. orcid.org/0000-0001-6488-7622, Wolkewitz, M., Schwab, C. et al. (125 more authors) (2023) Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity. Journal of Allergy and Clinical Immunology, 152 (4). 984-996.E10. ISSN 0091-6749

Mackie, SL orcid.org/0000-0003-2483-5873, Pease, CT, Fukuba, E et al. (5 more authors) (2015) Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids. Annals of the Rheumatic Diseases, 72 (12). pp. 2188-2192. ISSN 0003-4967

Macleod, T., Dubash, S., Hyde, I. et al. (9 more authors) (2024) P51 Plaque psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase compared with plaque psoriasis patients without arthritis. In: British Journal of Dermatology. 10th International Congress, Psoriasis: From Gene to Clinic, 05-07 Dec 2024, London, UK. Oxford University Press (OUP) , iii40.

Macleod, T, Bridgewood, C, Hyde, I et al. (4 more authors) (2022) Molecular and cellular regulation of psoriatic inflammation. Clinical Science, 136 (12). pp. 935-952. ISSN 0143-5221

Mahmood, F, English, B, Waxman, R et al. (1 more author) (2021) Development of an Instrument for Patient Self-assessment in Psoriatic Arthritis. Journal of Rheumatology, 48 (11). pp. 1680-1685. ISSN 0315-162X

Mahmoud, K, Zayat, A, Edwards, CJ et al. (5 more authors) (2016) An Evaluation of Clinical Outcome Measures for Musculoskeletal Lupus Using Ultrasound as A Gold Standard: Table 1. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ PUblishing Group , p. 556.

Mahmoud, K, Zayat, AS, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (12 more authors) (2021) Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study. Rheumatology, 60 (11). pp. 5194-5204. ISSN 1462-0324

Mahmoud, K, Zayat, AS, Yusof, Y et al. (4 more authors) (2019) Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus. Rheumatology, 58 (8). key422. pp. 1353-1360. ISSN 1462-0324

Mankia, K, D'Agostino, M-A and Emery, P orcid.org/0000-0002-7429-8482 (2020) Response to: 'Ultrasound findings in palindromic rheumatism' by Sanmarti et al. Annals of the Rheumatic Diseases, 79 (3). e31. ISSN 0003-4967

Mankia, K, D'Agostino, M-A, Murillo-González, J et al. (2 more authors) (2020) Response to: ‘Interosseous tendon inflammation of rheumatoid arthritis: what's the real meaning?’ by Deng et al. Annals of the Rheumatic Diseases, 79 (7). e84. ISSN 0003-4967

Mankia, K, D'Agostino, MA, Rowbotham, E et al. (12 more authors) (2019) MRI Inflammation of the Hand Interosseous Tendons occurs in anti-CCP positive at-risk individuals and may precede the development of clinical synovitis. Annals of the Rheumatic Diseases, 78 (6). pp. 781-786. ISSN 0003-4967

Mankia, K, D'Agostino, MA, Wakefield, RJ orcid.org/0000-0001-5352-8683 et al. (4 more authors) (2019) Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism. Annals of the Rheumatic Diseases, 78 (1). pp. 43-50. ISSN 0003-4967

Mankia, K and Emery, P orcid.org/0000-0002-7429-8482 (2019) Palindromic rheumatism as part of the rheumatoid arthritis continuum. Nature Reviews Rheumatology, 15 (11). pp. 687-695. ISSN 1759-4790

Mankia, K, Briggs, C and Emery, P orcid.org/0000-0002-7429-8482 (2020) How Are Rheumatologists Managing Anticyclic Citrullinated Peptide Antibodies–positive Patients Who Do Not Have Arthritis? Journal of Rheumatology, 47 (2). pp. 305-306. ISSN 0315-162X

Mankia, K, Cheng, Z, Do, T et al. (10 more authors) (2019) Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti–Cyclic Citrullinated Protein Antibody–Positive At-Risk Adults Without Arthritis. JAMA Network Open, 2 (6). e195394. ISSN 2574-3805

Mankia, K, Di Matteo, A orcid.org/0000-0003-0867-7051 and Emery, P orcid.org/0000-0002-7429-8482 (2020) Prevention and cure: The major unmet needs in the management of rheumatoid arthritis. Journal of Autoimmunity, 110. 102399. ISSN 0896-8411

Mankia, K and Emery, P orcid.org/0000-0002-7429-8482 (2021) Should we aim for personalized prevention in individuals at risk of rheumatoid arthritis? International Journal of Rheumatic Diseases, 24 (5). pp. 621-622. ISSN 1756-1841

Mankia, K, Gul, H and Emery, P orcid.org/0000-0002-7429-8482 (2021) Treating rheumatoid arthritis to an imaging target produces better outcomes, or does it? Rheumatology, 60 (1). pp. 3-4. ISSN 1462-0324

Mankia, K, Siddle, H, Di Matteo, A et al. (5 more authors) (2021) A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. RMD Open, 7 (3). e001768. ISSN 2056-5933

Mankia, K, Siddle, HJ orcid.org/0000-0002-6015-332X, Kerschbaumer, A et al. (17 more authors) (2021) EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Annals of the Rheumatic Diseases, 80 (10). pp. 1286-1298. ISSN 0003-4967

Marzo-Ortega, H, McGonagle, DG, Haugeberg, G et al. (3 more authors) (2003) Bone mineral density improvement in spondyloarthropathy after treatment with etanercept. Arthritis and Rheumatism, 62 (10). pp. 1020-1021. ISSN 0004-3591

Marzo-Ortega, H, Tan, AL orcid.org/0000-0002-9158-7243, Bissell, L-A et al. (4 more authors) (2020) Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic. The Lancet Rheumatology, 2 (7). E386-E387. ISSN 2665-9913

Marzo-Ortega, H orcid.org/0000-0002-9683-3407, Tan, AL orcid.org/0000-0002-9158-7243, McGonagle, D et al. (6 more authors) (2020) BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management. Rheumatology Advances in Practice, 4 (2). rkaa043. ISSN 2514-1775

Mathews, RJ, Robinson, JI orcid.org/0000-0001-5425-7520, Battellino, M et al. (17 more authors) (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Diseases, 73 (6). pp. 1202-1210. ISSN 0003-4967

Matteson, E.L. orcid.org/0000-0002-9866-0124, Matucci-Cerinic, M. orcid.org/0000-0002-9324-3161, Kreuter, M. et al. (6 more authors) (2023) Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD Open, 9 (3). e003059. ISSN 2056-5933

Maurer, M, Giménez‐Arnau, A, Bernstein, JA et al. (15 more authors) (2022) Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study. Allergy, 77 (7). pp. 2175-2184. ISSN 0105-4538

McGonagle, D, O’Donnell, JS, Sharif, K et al. (2 more authors) (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatology. ISSN 2665-9913

McGonagle, D., Haaland, D., Helliwell, P. et al. (6 more authors) (2022) 2113: Improvement in Key PsA Core Domains with Guselkumab Treatment in an Enriched Population of ACR20 Non-Responders at Week 24: Post Hoc Analysis of Two Phase 3 Studies. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. , pp. 4182-4184.

McGonagle, D., Haaland, D., Helliwell, P. orcid.org/0000-0002-4155-9105 et al. (6 more authors) (2023) Improvement in Key PsA Core Domains With Guselkumab Treatment in an Enriched Population of ACR20 Non-responders at Week 24: Post Hoc Analysis of Two Phase 3 Studies. In: ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, PA.

McGonagle, D, O'Donnell, JS, Sharif, K et al. (2 more authors) (2020) Pulmonary intravascular coagulopathy in COVID-19 pneumonia – Authors' reply. The Lancet Rheumatology, 2 (8). E460-E461. ISSN 2665-9913

McHugh, N., Tillett, W., Helliwell, P. orcid.org/0000-0002-4155-9105 et al. (7 more authors) (2024) Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial. Rheumatology. keae374. ISSN 1462-0324

McInnes, I, Mease, P, Hjuler, KF et al. (2 more authors) (2019) Brodalumab in psoriatic arthritis (PsA): 24-week results from the phase III AMVISON-1 and -2 trials. In: Journal of the American Academy of Dermatology. AAD 2019: American Academy of Dermatology Annual Meeting, 01-05 Mar 2019, Washington, DC, USA. Elsevier , AB28-AB28.

McMahan, Z., Pandolfino, J., Perlman, H. et al. (2 more authors) (2024) Gastrointestinal disease in systemic sclerosis: the neglected organ system? Current Opinion in Rheumatology, 36. ISSN 1040-8711

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Edward, S et al. (6 more authors) (2019) Validity and sensitivity to change of laser Doppler imaging as a novel objective outcome measure for cutaneous lupus erythematosus. Lupus, 28 (11). pp. 1320-1328. ISSN 0961-2033

Md Yusof, MY orcid.org/0000-0003-3131-9121, Candelier, JB, Dass, S et al. (3 more authors) (2016) Validation of B Cell Depletion as A Predictor of Clinical Response and Efficacy of Retreatment of Non-Response in Rheumatoid Arthritis. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 731.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (4 more authors) (2016) Incomplete and Systemic Lupus Erythematosus Reveal A Different Pattern of Interferon-Stimulated Genes Up-Regulation. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , pp. 285-286.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Iqbal, K, Emery, P orcid.org/0000-0002-7429-8482 et al. (2 more authors) (2016) Efficacy and Safety of Rituximab in Patients with Rheumatoid Arthritis-Related Bronchiectasis (RA-BR): Results from A Multicentre Cohort. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 996.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, Rawstron, A et al. (2 more authors) (2016) Validation of Highly Sensitive Flow Cytometry as A Biomarker for Rituximab in Sle: A Rationale for More Intensive Treatment To Improve Clinical Outcomes. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2016), 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 296.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, DM et al. (7 more authors) (2019) Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases. Arthritis & Rheumatology, 71 (11). pp. 1812-1823. ISSN 2326-5191

Md Yusof, M.Y. orcid.org/0000-0003-3131-9121, Smith, E.M.D. orcid.org/0000-0002-8371-7597, Ainsworth, S. et al. (32 more authors) (2023) Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope. Rheumatology Advances in Practice, 7 (3). rkad093. ISSN 2514-1775

Md Yusof, MY orcid.org/0000-0003-3131-9121, Arnold, J, Saleem, B et al. (5 more authors) (2023) Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study. The Lancet Rheumatology, 5 (2). e88-e98. ISSN 2665-9913

Md Yusof, MY orcid.org/0000-0003-3131-9121, Britton, J, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (4 more authors) (2017) Laser doppler imaging: an objective outcome measure for assessment of cutaneous lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , pp. 1019-1020.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Cassamoali, H, Rawstron, AC et al. (4 more authors) (2016) Humanized Anti-CD20 Antibodies Improve Depletion and Response in Systemic Lupus Erythematosus Patients with Resistance to Rituximab: Results from the First 100 Patients at a Single Centre. In: Rheumatology. Rheumatology 2016, 26-28 Apr 2016, Glasgow, UK. Oxford University Press , i46-i47.

Md Yusof, MY orcid.org/0000-0003-3131-9121, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Psarras, A et al. (6 more authors) (2017) Prediction of connective tissue disease in an at-risk cohort using a novel interferon stimulated gene expression score. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 91.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Psarras, A, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (9 more authors) (2018) Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. Annals of the Rheumatic Diseases, 77 (10). pp. 1432-1439. ISSN 0003-4967

Md Yusof, MY orcid.org/0000-0003-3131-9121, Robinson, J, El-Sherbiny, Y et al. (4 more authors) (2019) SAT0009 THE EFFECT OF FCGR3A POLYMORPHISM ON THE INITIAL DEPTH OF B-CELL DEPLETION BY RITUXIMAB, FUNCTIONAL NK-CELL MEDIATED KILLING AND CLINICAL RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOSUS. In: Annual European Congress of Rheumatology, EULAR 2019, 12-15 Jun 2019, Madrid, Spain.

Md Yusof, MY orcid.org/0000-0003-3131-9121, Shaw, D, El-Sherbiny, YM orcid.org/0000-0003-4791-3475 et al. (3 more authors) (2017) Predicting and managing primary and secondary non-response to rituximab using b-cell biomarkers in systemic lupus erythematosus. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 869.

Md Yusof, MY orcid.org/0000-0003-3131-9121 and Vital, EM orcid.org/0000-0003-1637-4755 (2022) Early intervention in systemic lupus erythematosus: time for action to improve outcomes and health-care utilization. Rheumatology Advances in Practice, 6 (1). rkab106. ISSN 2514-1775

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, Das, S et al. (5 more authors) (2015) Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions. Annals of the Rheumatic Diseases, 74 (9). pp. 1734-1738. ISSN 0003-4967

Md Yusof, MY orcid.org/0000-0003-3131-9121, Vital, EM orcid.org/0000-0003-1637-4755, McElvenny, D et al. (5 more authors) (2017) Risk factors for severe infection and rationale for immunoglobulin monitoring during rituximab treatment in autoimmune rheumatic diseases. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology (EULAR 2017), 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 987.

Md. Yusof, MY, Arnold, J, Saleem, B et al. (5 more authors) (2022) OP0250 BREAKTHROUGH INFECTIONS AND PREDICTING SEVERE COVID OUTCOMES DURING RITUXIMAB THERAPY IN AUTOIMMUNE RHEUMATIC DISEASES. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.

Mease, P, Coates, LC, Helliwell, PS et al. (14 more authors) (2018) Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. The Lancet, 392 (10162). pp. 2367-2377. ISSN 0140-6736

Mease, P. orcid.org/0000-0002-6620-0457, Helliwell, P. orcid.org/0000-0002-4155-9105, Silwinska‐Stanczyk, P. et al. (12 more authors) (2023) Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial. Arthritis & Rheumatology, 75 (8). pp. 1370-1380. ISSN 2326-5191

Mease, P.J., Helliwell, P., Gladman, D.D. et al. (10 more authors) (2022) POS1037 Effect Of Guselkumab, A Selective Il-23p19 Inhibitor, On Axial-Related Endpoints In Patients With Active Psa: Results From A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Through 2 Years. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 832-833.

Mease, P, Coates, L, Van den Bosch, F et al. (7 more authors) (2020) Effect of Filgotinib on the Complete Resolution of Enthesitis in Psoriatic Arthritis (PsA) Patients: 52-week Results from EQUATOR2. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Mease, P, Foley, P, Reich, K et al. (14 more authors) (2021) Low Incidence of Gastrointestinal-related and Overall Serious Adverse Events Among Guselkumab-treated Patients: Pooled Analyses of VOYAGE 1 & 2 and DISCOVER 1 & 2 Through 1-Year. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Mease, P, Helliwell, P orcid.org/0000-0002-4155-9105, Gladman, D et al. (10 more authors) (2022) Effect of Guselkumab a Selective IL-23p19 Inhibitor, on Axial-Related Endpoints in Patients With Active PsA: Results From a Phase 3, Randomized, Double-blind, Placebo-controlled Study Through 2 Years. In: Canadian Rheumatology Association Annual Meeting, 02-05 Feb 2022, Online.

Mease, P, Helliwell, P orcid.org/0000-0002-4155-9105, Gladman, D et al. (15 more authors) (2020) Efficacy of Guselkumab, a Monoclonal Antibody That Specifically Binds to the p19 Subunit of IL-23, on Axial-Related Endpoints in Patients with Active PsA with Imaging-Confirmed Sacroiliitis: Week-52 Results from Two Phase 3, Randomized, Double-blind, Placebo-controlled Studies. In: 37º Congresso Brasileiro de Reumatologia, 19-22 Nov 2020, Virtual.

Mease, P, Helliwell, P orcid.org/0000-0002-4155-9105, Gladman, D et al. (12 more authors) (2021) Efficacy of Guselkumab on Axial-Related Endpoints in Patients with Active Psoriatic Arthritis with Imaging-Confirmed Sacroiliitis. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Mease, P, Helliwell, PS orcid.org/0000-0002-4155-9105, Gladman, D et al. (10 more authors) (2021) Effect of Guselkumab (TREMFYA (R)), a Selective IL-23p19 Inhibitor, on Axial-Related Endpoints in Patients with Active PsA: Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Study Through 2 Years. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Mease, P, Helliwell, PS orcid.org/0000-0002-4155-9105, Silwinska-Stanczyk, P et al. (11 more authors) (2021) Efficacy and Safety of Brepocitinib (Tyrosine Kinase 2/Janus Kinase 1 Inhibitor) for the Treatment of Active Psoriatic Arthritis: Results from a Phase 2b Randomized Controlled Trial. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Mease, P, Orbai, A-M, FitzGerald, O et al. (5 more authors) (2021) Efficacy of Tofacitinib on Enthesitis in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Mease, PJ, Coates, LC, Van den Bosch, F et al. (8 more authors) (2021) Correlation Between Skin Involvement, Joint Involvement and Enthesitis in Patients with Active Psoriatic Arthritis: Post-hoc Analysis of EQUATOR/EQUATOR2. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Mease, PJ, Foley, P, Reich, K et al. (14 more authors) (2021) Low Incidence of Gastrointestinal-Related and Overall Serious Adverse Events among Guselkumab-Treated Patients: Pooled Analyses of Voyage 1 & 2 and Discover 1 & 2 Through 1-Year. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Mease, PJ, Gladman, DD, Collier, DH et al. (5 more authors) (2019) Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial. Arthritis & Rheumatology, 71 (7). pp. 1112-1124. ISSN 2326-5191

Mease, PJ, Gladman, DD, Deodhar, A et al. (9 more authors) (2020) Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study. RMD Open, 6 (2). e001217. ISSN 2056-5933

Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105, Gladman, DD et al. (14 more authors) (2021) Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies. The Lancet Rheumatology, 3 (10). e715-e723. ISSN 2665-9913

Mease, PJ, Palmer, JB, Hur, P et al. (7 more authors) (2019) Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry. Journal of the European Academy of Dermatology and Venereology, 33 (5). pp. 886-892. ISSN 0926-9959

Mease, PJ, Smolen, JS, Behrens, F et al. (11 more authors) (2020) A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Annals of the Rheumatic Diseases, 79 (1). pp. 123-131. ISSN 0003-4967

Melville, AR, Yusof, Y, Fitton, J orcid.org/0000-0002-7795-8191 et al. (6 more authors) (2021) Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis. Rheumatology. ISSN 1462-0324

Merashli, M, De Marco, G orcid.org/0000-0003-2406-161X, Tan, AL orcid.org/0000-0002-9158-7243 et al. (4 more authors) (2016) AB0700 Baseline Clinical Characteristics of The Leeds Sparro Early Psoriatic Arthritis Cohort: High Disease and Radiographic Involvement Are Seen Early Even in The Presence of Preserved Quality of Life. In: Annual European Congress of Rheumatology 2016, 08-11 Jun 2016, London, UK.

Merashli, M, Horton, L, Hensor, E orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2016) FRI0468 High Prevalence of Us Determined Subclinical Synovitis in Early Psoriatic Arthritis Correlates Better with The SJC Rather than TJC: Results from The Leeds Sparro Cohort. In: European League Against Rheumatism Annual Congress 2016, 08-11 Jun 2016, London, UK.

Merola, JF, Gottlieb, AB, Mease, P et al. (5 more authors) (2020) Psoriasis outcomes in a randomized trial of etanercept and methotrexate as monotherapy or in combination in patients with psoriatic arthritis. In: 2020 AAD VMX, 12-14 Jun 2020, Virtual.

Michaud, K, Pope, JE, Emery, P orcid.org/0000-0002-7429-8482 et al. (6 more authors) (2019) Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial. Rheumatology and Therapy, 6 (3). pp. 409-419. ISSN 2198-6584

Mohamed, AAA, El-Sherbiny, Y orcid.org/0000-0003-4791-3475, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (6 more authors) (2016) Type I Interferon Activity Is Associated with Mucocutaneous but Not Musculoskeletal Disease Activity in Systemic Lupus Erythematosus:. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 547.

Mongin, D., Matucci-Cerinic, M., Walker, U. et al. (15 more authors) (2024) POS0832 Immunosuppression Versus Combination Of Immunosuppression And Oral Glucocorticoids For Skin Fibrosis In Early Diffuse Systemic Sclerosis Patients. A Target Trial Emulation Study From The Eustar Database. In: Annals of the Rheumatic Diseases. EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria. BMJ Publishing Group .

Mongin, D., Matucci‐Cerinic, M., Walker, U.A. et al. (16 more authors) (2024) Oral glucocorticoids for skin fibrosis in early diffuse systemic sclerosis: a target trial emulation study from the European Scleroderma Trials and Research group database. Arthritis Care & Research. ISSN 2151-464X

Moran, E, Cook, T, Goodman, AL et al. (8 more authors) (2021) Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials. The Lancet Infectious Diseases, 21 (10). pp. 1345-1347. ISSN 1473-3099

Morgan, AW orcid.org/0000-0003-1109-624X, Robinson, JI orcid.org/0000-0001-5425-7520, Conaghan, PG orcid.org/0000-0002-3478-5665 et al. (10 more authors) (2010) Evaluation of the rheumatoid arthritis susceptibility loci HLA-DRB1, PTPN22, OLIG3/TNFAIP3, STAT4 and TRAF1/C5 in an inception cohort. Arthritis Research, 12 (2). R57. R57-R57. ISSN 1465-9913

Mortimer, I, Bissell, LA, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (12 more authors) (2019) Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis. Rheumatology, 58 (9). kez114. pp. 1684-1686. ISSN 1462-0324

Mughal, S, Moghul, I, Yu, J et al. (28 more authors) (2017) Pheno4J: A gene to phenotype graph database. Bioinformatics, 33 (20). pp. 3317-3319. ISSN 1367-4803

Mulder, M.L.M., Vriezekolk, J.E., Van Hal, T. et al. (7 more authors) (2022) POS0078 Comparing Methotrexate Monotherapy With Methotrexate Plus Leflunomide Combination Therapy In Psoriatic Arthritis: A Randomised, Placebo-Controlled, Double-Blind Clinical Trial (Complete-PsA). In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , p. 259.

Mulder, MLM, Vriezekolk, JE, van Hal, TW et al. (7 more authors) (2022) Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial. The Lancet Rheumatology, 4 (4). e252-e261. ISSN 2665-9913

Myasoedova, E, Athreya, AP, Crowson, CS et al. (15 more authors) (2022) Towards Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: a Pharmacogenomics-driven Machine Learning Approach. Arthritis Care and Research, 74 (6). pp. 879-888. ISSN 2151-464X

N

Nam, JL, Villeneuve, E, Hensor, EM orcid.org/0000-0002-5245-4755 et al. (13 more authors) (2014) Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Annals of the Rheumatic Diseases, 73 (1). pp. 75-85. ISSN 0003-4967

Nash, P, Kerschbaumer, A, Dörner, T et al. (26 more authors) (2021) Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. Annals of the Rheumatic Diseases, 80 (1). pp. 71-87. ISSN 0003-4967

O

Ogdie, A, Weinstein, S, Coates, LC et al. (2 more authors) (2020) SAT0433 TRIAL SIMULATION TO INFORM ENROLLMENT CRITERIA AND OUTCOME MEASURES FOR PRAGMATIC TRIALS IN PsA. In: EULAR 2020, 03-06 Jun 2020, Online.

Orbai, AM, Coates, LC, Deodhar, A et al. (8 more authors) (2020) AB0813 GUSELKUMAB-TREATED PATIENTS ACHIEVED CLINICALLY MEANINGFUL IMPROVEMENT IN SYSTEMIC SYMPTOMS AS MEASURED WITH PROMIS INSTRUMENT: RESULTS FROM PHASE-3 PSORIATIC ARTHRITIS TRIAL DISCOVER 1. In: EULAR 2020, 03-06 Jun 2020, Online.

Orbai, A-M, Coates, L, Deodhar, A et al. (8 more authors) (2020) Guselkumab-Treated Patients Achieved Clinically Meaningful Improvement in Systemic Symptoms as Measured with PROMIS Instrument: Results from Phase-3 Psoriatic Arthritis Trial DISCOVER 1. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Orbai, A-M, Coates, L, Deodhar, A et al. (9 more authors) (2021) Guselkumab-Treated Patients with Psoriatic Arthritis Achieved Clinically Meaningful Improvements in General Health Outcomes Measured with PROMIS-29 Through 52 Weeks: Results from the Phase 3 DISCOVER-1 Trial. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Orbai, A-M, Coates, LC, Deodhar, A et al. (10 more authors) (2022) Meaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study. The Patient: Patient Centered Outcomes Research, 15 (6). pp. 657-668. ISSN 1178-1653

Orbai, A-M, Mease, P, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (5 more authors) (2020) Efficacy of Tofacitinib on Dactylitis in Individual Digits in Patients with Active Psoriatic Arthritis. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Orbai, A-M, Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (4 more authors) (2022) Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studies. BMC Rheumatology, 6 (1). 68. ISSN 2520-1026

Orbai, AM, Coates, LC, Deodhar, A et al. (9 more authors) (2021) Guselkumab-Treated Patients with Psoriatic Arthritis Achieved Clinically Meaningful Improvements in General Health Outcomes Measured with PROMIS-29 Through 52 Weeks: Results from the Phase 3 Discover-1 Trial. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Orbai, AM, Mease, PJ, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (5 more authors) (2021) Efficacy of Tofacitinib on Dactylitis in Individual Digits in Patients with Active Psoriatic Arthritis. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Orozco, G, Hinks, A, Eyre, S et al. (19 more authors) (2009) Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Human Molecular Genetics, 18 (14). pp. 2693-2699. ISSN 0964-6906

Orr, C, Vieira-Sousa, E, Boyle, DL et al. (26 more authors) (2017) Synovial tissue research: a state-of-the-art review. Nature Reviews Rheumatology, 13 (8). pp. 463-475. ISSN 1759-4790

Ouboussad, L, Hunt, L, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (5 more authors) (2017) Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis. Arthritis Research and Therapy, 19. 288. ISSN 1478-6354

P

Palominos, PE, Fernández-Ávila, DG, Coates, LC et al. (18 more authors) (2022) Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations. The Journal of Rheumatology, 49 (11). jrheum.220311. ISSN 0315-162X

Pan, Y, Norton, S, Gwinnutt, JM et al. (7 more authors) (2019) Not all moderate disease is the same – Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity. PLOS ONE, 14 (5). e0215999. ISSN 1932-6203

Panagiotou, ES, Sanjurjo Soriano, C, Poulter, JA orcid.org/0000-0003-2048-5693 et al. (15 more authors) (2017) Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR. The American Journal of Human Genetics, 100 (6). pp. 960-968. ISSN 0002-9297

Parato, VM, Corradini, D, Di Matteo, A orcid.org/0000-0003-0867-7051 et al. (1 more author) (2019) An unusual interventricular septal bounce in a patient with dermatomyositis: a case report. European Heart Journal - Case Reports, 3 (2). pp. 1-5. ISSN 2514-2119

Parry, DA, Smith, CEL orcid.org/0000-0001-8320-5105, El-Sayed, W et al. (17 more authors) (2016) Mutations in the pH-Sensing G-protein-Coupled Receptor GPR68 Cause Amelogenesis Imperfecta. American Journal of Human Genetics, 99 (4). pp. 984-990. ISSN 0002-9297

Pathak, S, Rowczenio, D, Lara-Reyna, S et al. (8 more authors) (2020) Evidence of B Cell Clonality and Investigation Into Properties of the IgM in Patients With Schnitzler Syndrome. Frontiers in Immunology, 11. 569006. ISSN 1664-3224

Peckham, D orcid.org/0000-0001-7723-1868, McDermott, MF orcid.org/0000-0002-1015-0745, Savic, S orcid.org/0000-0001-7910-0554 et al. (1 more author) (2020) COVID-19 meets Cystic Fibrosis: for better or worse? Genes & Immunity, 21 (4). pp. 260-262. ISSN 1466-4879

Pedicini, L., Smith, J., Savic, S. orcid.org/0000-0001-7910-0554 et al. (1 more author) (2023) Rab46: a novel player in mast cell function. Discovery Immunology, 3 (1). kyad028. ISSN 2754-2483

Pedicini, L, Savic, S orcid.org/0000-0001-7910-0554 and Mckeown, L orcid.org/0000-0003-2326-7595 (2021) Rab46 is a novel mast cell gtpase localised to secretory granules. In: European Academy of Allergy and Clinical Immunology Hybrid Congress, 10-12 Jul 2021, Krakow, Poland.

Pepple, S, Arnold, J, Vital, EM orcid.org/0000-0003-1637-4755 et al. (5 more authors) (2022) Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome. ACR Open Rheumatology, 4 (8). pp. 689-699. ISSN 2578-5745

Perez-Witzke, D, Parmar, R, Blanc, I et al. (2 more authors) (2021) Development of a long-term, IL7 dependent cell death rescue assay in CD4+ T-cells. Journal of Immunological Methods, 493. 113020. ISSN 0022-1759

Peterfy, C, DiCarlo, J, Emery, P orcid.org/0000-0002-7429-8482 et al. (7 more authors) (2019) Use of Magnetic Resonance Imaging to Support Dose Selection in a Phase II Trial of Baricitinib Combined with Conventional Synthetic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis. Journal of Rheumatology, 46 (8). pp. 887-895. ISSN 0315-162X

Pitaksalee, R orcid.org/0000-0002-6488-2108, Burska, AN orcid.org/0000-0003-3321-9087, Ajaib, S et al. (11 more authors) (2020) Differential CpG DNA methylation in peripheral naïve CD4+ T-cells in early rheumatoid arthritis patients. Clinical Epigenetics, 12. 54. ISSN 1868-7075

Plein, S orcid.org/0000-0002-0997-4384, Erhayiem, B, Fent, G et al. (9 more authors) (2020) Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis. Annals of the Rheumatic Diseases, 79 (11). pp. 1414-1422. ISSN 0003-4967

Poddubnyy, D, Mease, PJ, Van den Bosch, F et al. (9 more authors) (2020) AB0824 WHICH PARAMETERS ARE RELEVANT IN THE IDENTIFYING AXIAL INVOLVEMENT IN PSORIATIC ARTHRITIS? – RESULTS OF A SURVEY AMONG ASAS AND GRAPPA MEMBERS. In: EULAR 2020, 03-06 Jun 2020, Online.

Ponchel, F orcid.org/0000-0002-3969-7701, Burska, A orcid.org/0000-0003-3321-9087, Hunt, L et al. (6 more authors) (2020) T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management. Scientific Reports, 10. 3669. ISSN 2045-2322

Ponchel, F orcid.org/0000-0002-3969-7701, Burska, AN orcid.org/0000-0003-3321-9087, Hensor, EMA orcid.org/0000-0002-5245-4755 et al. (4 more authors) (2015) Changes in peripheral blood immune cell composition in osteoarthritis. Osteoarthritis and Cartilage, 23 (11). pp. 1870-1878. ISSN 1063-4584

Ponchel, F orcid.org/0000-0002-3969-7701, Churchman, S, El-Jawhari, JJ et al. (8 more authors) (2021) Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium. Clinical and Experimental Rheumatology, 39 (2). ISSN 0392-856X

Ponchel, F orcid.org/0000-0002-3969-7701, Duquenne, L, Xie, X et al. (5 more authors) (2022) Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals. RMD Open, 8 (2). e002512. ISSN 2056-5933

Ponchel, F orcid.org/0000-0002-3969-7701, van Delft, MA, Xie, X orcid.org/0000-0002-1474-9931 et al. (4 more authors) (2021) Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis? Clinical and Experimental Rheumatology, 39 (1). 0146-0150. ISSN 0392-856X

Pontarini, E. orcid.org/0000-0003-0439-0344, Sciacca, E. orcid.org/0000-0001-7525-1558, Chowdhury, F. et al. (28 more authors) (2024) Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS). Arthritis & Rheumatology, 76 (5). pp. 763-776. ISSN 2326-5191

Poulter, J orcid.org/0000-0003-2048-5693, UKGCA/VEXAS Consortium, Morgan, A orcid.org/0000-0003-1109-624X et al. (2 more authors) (2022) A High-Throughput Amplicon Screen for Somatic UBA1 Variants in Cytopenic and Giant Cell Arteritis Cohorts. Journal of Clinical Immunology, 42 (5). pp. 947-951. ISSN 0271-9142

Poulter, JA orcid.org/0000-0003-2048-5693, Collins, JC, Cargo, C et al. (12 more authors) (2021) Novel somatic mutations in UBA1 as a cause of VEXAS syndrome. Blood. ISSN 0006-4971

Poulter, JA orcid.org/0000-0003-2048-5693 and Savic, S orcid.org/0000-0001-7910-0554 (2021) Genetics of somatic auto-inflammatory disorders. Seminars in Hematology, 58 (4). pp. 212-217. ISSN 0037-1963

Poulton, K, Wright, P, Hughes, P et al. (8 more authors) (2020) A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients. International Journal of Immunogenetics, 47 (4). pp. 324-328. ISSN 1744-3121

Psarras, A, Alase, A, Antanaviciute, A et al. (6 more authors) (2020) Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity. Nature Communications, 11. 6149. ISSN 2041-1723

Psarras, A, Antanaviciute, A, Alase, A et al. (5 more authors) (2021) TNF-α Regulates Human Plasmacytoid Dendritic Cells by Suppressing IFN-α Production and Enhancing T Cell Activation. The Journal of Immunology. ji1901358. ISSN 0022-1767

Q

Quinn, MA, Green, MJ, Marzo-Ortega, H et al. (5 more authors) (2003) Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis and Rheumatism, 48 (11). pp. 3039-3045. ISSN 0004-3591

R

RA-MAP Consortium (2021) Characterization of disease course and remission in early seropositive rheumatoid arthritis: results from the TACERA longitudinal cohort study. Therapeutic Advances in Musculoskeletal Disease, 13. ARTN 1759720X211043977. pp. 1-17. ISSN 1759-720X

Rabin, T, De Marco, G, Dubash, SR et al. (5 more authors) (2023) Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis. Clinical and Experimental Rheumatology, 41 (3). 11/07/2022. 0694-0703.

Rahman, P, Ritchlin, CT, Helliwell, P et al. (13 more authors) (2020) FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS. In: EULAR 2020, 03-06 Jun 2020, Online.

Rahman, P, Helliwell, P orcid.org/0000-0002-4155-9105, Deodhar, A et al. (6 more authors) (2021) In Phase-3 Trials Discover 1 & 2, Guselkumab Reduced Fatigue over 52 Weeks in Patients with Psoriatic Arthritis and Demonstrated Independent Treatment Effects on Fatigue after Adjustment for Clinical Response (ACR20). In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Rahman, P, Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (10 more authors) (2021) Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response—results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis. Arthritis Research and Therapy, 23 (1). 190. ISSN 1478-6354

Rahman, P, Ritchlin, C, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (12 more authors) (2021) Integrated Safety Results of Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis through the Placebo-Controlled Periods. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Rahman, P, Ritchlin, C, Mease, P et al. (10 more authors) (2022) Long-term Safety of Guselkumab in Patients With Active Psoriatic Arthritis: Pooled Results From 3 Randomized Clinical Trials Through Up to 2 Years. In: Open Access Canadian Rheumatology Association Annual Meeting, 02-05 Feb 2022, Online.

Rahman, P, Ritchlin, C, Mease, P et al. (11 more authors) (2021) Long-term Safety of Guselkumab (TREMFYA (R)) in Patients with Active Psoriatic Arthritis: Pooled Results from 3 Randomized Clinical Trials Through up to 2 Years. In: ACR Convergence 2021, 05-09 Nov 2021, Online.

Rakieh, C, Nam, JL, Hunt, L et al. (10 more authors) (2015) Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Annals of the Rheumatic Diseases, 74 (9). pp. 1659-1666. ISSN 0003-4967

Ridgley, LA, Anderson, AE, Maney, NJ et al. (7 more authors) (2019) IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector Function. Frontiers in Immunology, 10. 1535. ISSN 1664-3224

Riedl, M.A., Farkas, H., Aygören-Pürsün, E. et al. (28 more authors) (2024) Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks. New England Journal of Medicine, 391 (1). pp. 32-43. ISSN 0028-4793

Ritchlin, C, Ogdie, A, Giles, J et al. (9 more authors) (2019) Impact of Baseline Body Mass Index on the Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis. In: 2019 ACR/ARP Annual Meeting, 08-13 Nov 2019, Atlanta, Georgia, USA.

Ritchlin, CT, Helliwell, P, Boehncke, WH et al. (8 more authors) (2020) SAT0397 GUSELKUMAB, AN IL-23 INHIBITOR THAT SPECIFICALLY BINDS TO THE IL23P19-SUBUNIT, FOR ACTIVE PSORIATIC ARTHRITIS: ONE YEAR RESULTS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF PATIENTS WHO WERE BIOLOGIC-NAÏVE OR TNFΑ INHIBITOR-EXPERIENCED. In: EULAR 2020, 03-06 Jun 2020, Online.

Ritchlin, CT, Ogdie, A, Giles, JT et al. (9 more authors) (2020) AB0827 IMPACT OF BASELINE BODY MASS INDEX ON THE EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS. In: EULAR 2020, 03-06 Jun 2020, Online.

Ritchlin, C.T. orcid.org/0000-0002-2602-1219, Deodhar, A. orcid.org/0000-0002-2130-1246, Boehncke, W. et al. (8 more authors) (2023) Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR Open Rheumatology, 5 (3). pp. 149-164. ISSN 2578-5745

Ritchlin, C, Deodhar, A, Boehncke, W-H et al. (10 more authors) (2020) Guselkumab Efficacy and Safety in TNF-Inhibitor-Experienced and TNF-Inhibitor-Naive Patients with Active PsA: 1-Year Results of a Phase 3, Randomized, Controlled Study. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Ritchlin, C, Helliwell, P orcid.org/0000-0002-4155-9105, Boehncke, W-H et al. (8 more authors) (2020) Guselkumab, an IL-23 Inhibitor That Specifically Binds to the IL23p19-Subunit, for Active Psoriatic Arthritis: One Year Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Patients Who Were Biologic-Naïve or TNFα Inhibitor-Experienced. In: ACR Convergence 2020, 05-09 Nov 2020, Virtual.

Ritchlin, CT, Giles, JT, Ogdie, A et al. (8 more authors) (2020) Tofacitinib in Patients With Psoriatic Arthritis and Metabolic Syndrome: A Post hoc Analysis of Phase 3 Studies. ACR Open Rheumatology, 2 (10). pp. 543-554. ISSN 2578-5745

Ritchlin, CT, Rahman, P, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (13 more authors) (2021) Pooled Safety Results from Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis through 1 Year. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Ritchlin, CT, Rahman, P, Helliwell, PS orcid.org/0000-0002-4155-9105 et al. (7 more authors) (2021) Safety of guselkumab in patients with psoriatic arthritis through 1 year: Pooled findings from DISCOVER-1 and DISCOVER-2 phase 3 trials. In: AAD VMX 2021, 23-25 Apr 2021, Virtual.

Robinson, JI orcid.org/0000-0001-5425-7520, Md Yusof, MY orcid.org/0000-0003-3131-9121, Davies, V et al. (20 more authors) (2022) Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. eBioMedicine, 86. 104343. ISSN 2352-3964

Rodríguez-Carrio, J., Burska, A., Conaghan, P.G. orcid.org/0000-0002-3478-5665 et al. (14 more authors) (2023) 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice. Annals of the Rheumatic Diseases, 82 (6). pp. 754-762. ISSN 0003-4967

Romão, VC, Vital, EM orcid.org/0000-0003-1637-4755, Fonseca, JE et al. (1 more author) (2017) Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis? Arthritis Research & Therapy, 19 (1). 239. ISSN 1478-6354

Rooney, CM, Mankia, K and Emery, P orcid.org/0000-0002-7429-8482 (2020) The role of the microbiome in driving RA-related autoimmunity. Frontiers in Cell and Developmental Biology, 8. 538130. ISSN 2296-634X

Rooney, CM, Mankia, K, Mitra, S orcid.org/0000-0002-9378-1496 et al. (3 more authors) (2020) Perturbations of the gut microbiome in anti-CCP positive individuals at risk of developing rheumatoid arthritis. Rheumatology. ISSN 1462-0324

Rosas, IO, Bräu, N, Waters, M et al. (20 more authors) (2021) Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. New England Journal of Medicine, 384 (16). pp. 1503-1516. ISSN 0028-4793

Rosas, IO, Bräu, N, Waters, M et al. (34 more authors) (2022) Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA). EClinicalMedicine, 47. 101409. ISSN 2589-5370

Ross, R., Clarke, E., Merchant, W. et al. (8 more authors) (2023) POS0146 biosamples from vedoss patients show classic pathological signs of scleroderma:opportunity for a biological diagnosis of disease. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Ross, R.L., Caballero-Ruiz, B., Clarke, E.L. et al. (11 more authors) (2024) Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of SSc (VEDOSS). Rheumatology. keae698. ISSN 1462-0324

Ross, R.L., Clarke, E., Merchant, W. et al. (8 more authors) (2023) P162 Biosamples from VEDOSS patients show classic pathological signs of Scleroderma: Opportunity for a biological diagnosis of disease. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 2023-04-24 2023-04-26, Manchester, UK. Oxford University Press .

Ross, R.L., Georgiou, I., Carriero, A. et al. (6 more authors) (2020) P163 Biosamples from at risk SSc patients show classic pathological signs of scleroderma: opportunity for a diagnosis of pre-clinical SSc. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press .

Roth, E., Bruni, C., Petelytska, L. et al. (18 more authors) (2024) POS0230 Characteristics and disease course of SSc-ILD patients with gastroesophageal reflux – an analysis of the EUSTAR cohort. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Ruscitti, P., Allanore, Y., Baldini, C. et al. (70 more authors) (2024) Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus. Autoimmunity Reviews, 23 (7-8). 103581. ISSN 1568-9972

Rutkowski, K, Wagner, A, Jui-Lin Choo, K et al. (3 more authors) (2021) “Omalizumab plus”: Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series. Journal of Allergy and Clinical Immunology: In Practice, 9 (3). 1400-1401.e2. ISSN 2213-2198

S

Sahin, D., Di Matteo, A. and Emery, P. orcid.org/0000-0002-7429-8482 (2025) Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: A comprehensive review. Annals of Clinical Biochemistry, 62 (1). 3 -21. ISSN 0004-5632

Sajawal, S., Green, M. and Savic, S. orcid.org/0000-0001-7910-0554 (2022) A patient with systemic inflammation, relapsing polychondritis and pancytopaenia: VEXAS. In: Rheumatology. British Society for Rheumatology Annual Conference 2022, 25-27 Apr 2022, Glasgow, UK. Oxford University Press .

Saleem, B, Ross, RL, Bissell, L-A et al. (20 more authors) (2022) Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses. RMD Open, 8 (1). e002050. ISSN 2056-5933

Saleem, B, Ross, RL, Duquenne, L et al. (2 more authors) (2022) COVID-19 vaccine-induced T-cell responses in patients with rheumatoid arthritis: preferential induction by ChAdOx1. The Lancet Rheumatology, 4 (3). e171-e172. ISSN 2665-9913

Sanjurjo-Rodriguez, C, Baboolal, TG, Burska, AN orcid.org/0000-0003-3321-9087 et al. (5 more authors) (2019) Gene expression and functional comparison between multipotential stromal cells from lateral and medial condyles of knee osteoarthritis patients. Scientific Reports, 9. 9321. ISSN 2045-2322

Santiago, T. orcid.org/0000-0002-1562-4022, Santos, E.J.F. orcid.org/0000-0003-0557-2377, Ruaro, B. et al. (13 more authors) (2022) Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group. RMD Open, 8 (2). e002371. ISSN 2056-5933

Santillo, M, Wanat, M, Davoudianfar, M et al. (9 more authors) (2020) Developing a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice and subsequently change antibiotic use. BMJ Open, 10 (10). e035793. ISSN 2044-6055

Savage, L, Goodfield, M, Horton, L et al. (6 more authors) (2019) Regression of peripheral subclinical enthesopathy in therapy-naïve patients treated with Ustekinumab for moderate-to-severe chronic plaque psoriasis: A Fifty‐Two–Week, Prospective, Open‐Label Feasibility Study. Arthritis and Rheumatology, 71 (4). pp. 626-631. ISSN 2326-5191

Savic, L, Savic, S orcid.org/0000-0001-7910-0554 and Hopkins, PM orcid.org/0000-0002-8127-1739 (2020) Anaphylaxis to sugammadex: should we be concerned by the Japanese experience? British Journal of Anaesthesia, 124 (4). pp. 370-372. ISSN 0007-0912

Savic, L, Thomas, C, Fallaha, D et al. (4 more authors) (2020) Drug allergy labels in elective surgical patients: what do patients and their anaesthetists think about penicillin allergy labels? In: BJA Research Forum 2019, 02-03 Dec 2019, York, UK.

Savic, S orcid.org/0000-0001-7910-0554, Caseley, EA orcid.org/0000-0001-7591-143X and McDermott, MF orcid.org/0000-0002-1015-0745 (2020) Moving towards a systems-based classification of innate immune-mediated diseases. Nature Reviews Rheumatology, 16 (4). pp. 222-237. ISSN 1759-4790

Savic, S orcid.org/0000-0001-7910-0554, Ouboussad, L, Dickie, LJ et al. (10 more authors) (2014) TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. Journal of Autoimmunity, 50. pp. 59-66. ISSN 0896-8411

Savic, L, Hopkins, P orcid.org/0000-0002-8127-1739, Ford, K et al. (2 more authors) (2019) Drug provocation testing (DPT) to exclude neuromuscular blocking agent (NMBA) allergy: a case report. In: Clinical and Experimental Allergy. BSACI Annual Meeting, 03-05 Oct 2019, Harrogate, UK. , p. 1664.

Savic, L, Thomas, C, Fallaha, D et al. (5 more authors) (2020) DALES, Drug Allergy Labels in Elective Surgical patients: a prospective multicentre cross-sectional study of incidence, risks, and attitudes in penicillin de-labelling strategies. British Journal of Anaesthesia, 125 (6). pp. 962-969. ISSN 0007-0912

Savic, LC, Savic, S orcid.org/0000-0001-7910-0554 and Pearse, RM (2022) Mandatory vaccination of National Health Service staff against COVID-19: more harm than good? British Journal of Anaesthesia, 128 (4). pp. 608-609. ISSN 0007-0912

Savic, S orcid.org/0000-0001-7910-0554, Leeman, L, El-Shanawany, T et al. (11 more authors) (2020) Chronic urticaria in the real‐life clinical practice setting in the UK: results from the non‐interventional multicentre AWARE study. Clinical and Experimental Dermatology, 45 (8). pp. 1003-1010. ISSN 0307-6938

Schreiber, S, Puig, L, Gonçalves, J et al. (3 more authors) (2022) Critical Appraisal and Future Outlook on Anti-Inflammatory Biosimilar Use in Chronic Immune-Mediated Inflammatory Diseases. Seminars in Arthritis and Rheumatism, 55. 152023. ISSN 0049-0172

Segal Salto, M., Mor, A. and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2022) POS0489 CCL24 Serum Concentration Correlates With Disease Activity And Worse Prognosis In Diffuse Cutaneous Ssc: A Promising Biological Target To Prevent Disease Progression. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , 499.1-49499.

Segú-Vergés, C, Gómez, J, Terradas, P et al. (4 more authors) (2023) Unveiling chronic spontaneous urticaria pathophysiology through systems biology. Journal of Allergy and Clinical Immunology, 151 (4). pp. 1005-1014. ISSN 0091-6749

Sgrò, P., Antinozzi, C., Wasson, C.W. et al. (3 more authors) (2024) Sexual Dimorphism in Sex Hormone Metabolism in Human Skeletal Muscle Cells in Response to Different Testosterone Exposure. Biology, 13 (10). 796. ISSN 2079-7737

Shears, A, Steele, C, Craig, J et al. (6 more authors) (2022) Clinical Outcome and Underlying Genetic Cause of Functional Terminal Complement Pathway Deficiencies in a Multicenter UK Cohort. Journal of Clinical Immunology, 42 (3). pp. 665-671. ISSN 0271-9142

Shields, AM, Burns, SO, Savic, S orcid.org/0000-0001-7910-0554 et al. (1 more author) (2021) COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience. Journal of Allergy and Clinical Immunology, 147 (3). 870-875.e1. ISSN 0091-6749

Shields, AM, Faustini, SE, Hill, HJ et al. (25 more authors) (2022) Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study. Frontiers in Immunology, 13. 912571. ISSN 1664-3224

Shields, AM, Faustini, SE, Hill, HJ et al. (22 more authors) (2022) SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study. Journal of Clinical Immunology, 42 (5). pp. 923-934. ISSN 0271-9142

Shields, AM, Tadros, S, Al-Hakim, A et al. (20 more authors) (2022) Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience. Frontiers in Immunology, 13. 984376. ISSN 1664-3224

Shukla, R., Dumitru, R.B., Erhayiem, B. et al. (5 more authors) (2024) P143 High throughput multiplex assay identifies clinically meaningful clusters in systemic sclerosis patients with low cardiovascular risk and no history of heart disease. In: Rheumatology. British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool, United Kingdom. Oxford University Press .

Shukla, R, Emery, P orcid.org/0000-0002-7429-8482 and Buch, MH orcid.org/0000-0002-8962-5642 (2021) Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the ‘VEDERA’ trial. Rheumatology. ISSN 1462-0324

Siddle, HJ orcid.org/0000-0002-6015-332X, Redmond, AC orcid.org/0000-0002-8709-9992, Waxman, R et al. (4 more authors) (2013) Debridement of painful forefoot plantar callosities in rheumatoid arthritis: the CARROT randomised controlled trial. Clinical Rheumatology, 32 (5). pp. 567-574. ISSN 0770-3198

Siddle, H.J., Wilson, M., Nam, J.L. et al. (5 more authors) (2024) A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary care. Rheumatology. keae653. ISSN 1462-0324

Siddle, HJ orcid.org/0000-0002-6015-332X, Bradley, SH orcid.org/0000-0002-2038-2056, Anderson, AM orcid.org/0000-0002-4048-6880 et al. (3 more authors) (2023) Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice. British Journal of General Practice, 73 (729). pp. 152-154. ISSN 0960-1643

Siddle, HJ orcid.org/0000-0002-6015-332X, Chapman, LS, Mankia, K et al. (9 more authors) (2022) Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies. Annals of the Rheumatic Diseases, 81 (2). pp. 159-168. ISSN 0003-4967

Smith, C orcid.org/0000-0001-8320-5105, Whitehouse, L, Poulter, J orcid.org/0000-0003-2048-5693 et al. (8 more authors) (2020) A missense variant in specificity protein 6 (SP6) is associated with amelogenesis imperfecta. Human Molecular Genetics. ISSN 0964-6906

Smith, H., Denman, S., Arumugakani, G. et al. (2 more authors) (2023) Non-response to omalizumab in patients with chronic spontaneous urticaria (CSU): A 10-year real-world UK study. In: Clinical & Experimental Allergy. BSACI Annual Conference 2023, 05-07 Oct 2023, Harrogate, UK. Wiley , p. 1082.

Smith, M., Iverson, M., Hansen, E. et al. (2 more authors) (2023) A Comparative Bioavailability of Sebetralstat Following Administration of Orally Disintegrating Tablets and Film-Coated Tablets in Healthy Volunteers. In: Journal of Allergy and Clinical Immunology. 2023 AAAAI Annual Meeting, 24-27 Feb 2023, San Antonio, USA. Elsevier , AB140-AB140.

Smith, M.D., Duckworth, E.J., Hampton, S.L. et al. (3 more authors) (2022) Oral KVD900 provides rapid inhibition of plasma kallikrein and fast improvement in attack symptoms in patients with hereditary angioedema. In: Eastern Allergy Conference, 02-05 Jun 2022, Palm Beach, Florida.

Smolen, JS, Landewé, RB, Bijlsma, JWJ et al. (44 more authors) (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the Rheumatic Diseases. ISSN 0003-4967

Smolen, JS, Pangan, AL, Emery, P orcid.org/0000-0002-7429-8482 et al. (9 more authors) (2019) Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study. The Lancet, 393 (10188). pp. 2303-2311. ISSN 0140-6736

Smolen, JS, Choe, J-Y, Weinblatt, ME et al. (7 more authors) (2020) Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis. RMD Open, 6 (1). e001096. ISSN 2056-5933

Smolen, JS, Kang, YM, Yoo, WH et al. (7 more authors) (2020) Radiographic Progression Based on Baseline Characteristics From TNF Inhibitor Biosimilar Studies in Patients With Rheumatoid Arthritis. Arthritis Research and Therapy, 22. 188. ISSN 1478-6354

Soomro, M, Stadler, M, Dand, N et al. (60 more authors) (2022) Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling. Arthritis and Rheumatology, 74 (9). pp. 1535-1543. ISSN 2326-5191

Spiera, R. orcid.org/0000-0003-2911-6800, Kuwana, M. orcid.org/0000-0001-8352-6136, Khanna, D. orcid.org/0000-0003-1412-4453 et al. (28 more authors) (2023) Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology, 75 (9). pp. 1608-1618. ISSN 2326-5191

Spierings, J., Ong, V.H., Welsing, P.M.J. et al. (5 more authors) (2024) P139 Self-assessment of scleroderma skin: validation of the PASTUL questionnaire. In: British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool.

Spierings, J., Welsing, P.M.J., Colak, S. et al. (7 more authors) (2024) Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL. Rheumatology. keae561. ISSN 1462-0324

Stock, C., Kreuter, M., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (7 more authors) (2021) PRS3 Joint Modelling of Forced Vital Capacity Decline and Time to Hospitalization Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease. In: Virtual ISPOR 2021, 17-20 May 2021, Online.

Stockdale, C, Rice, L, Carter, C et al. (7 more authors) (2021) Novel Case of Tripeptidyl Peptidase 2 Deficiency Associated with Mild Clinical Phenotype. Journal of Clinical Immunology, 41 (5). pp. 1123-1127. ISSN 0271-9142

Stremenova Spegarova, J, Lawless, D orcid.org/0000-0001-8496-3725, Mohamad, SMB et al. (24 more authors) (2020) Germline TET2 loss of function causes childhood immunodeficiency and lymphoma. Blood, 136 (9). pp. 1055-1066. ISSN 0006-4971

Suliman, Y., Kafaja, S., Oh, S.J. et al. (12 more authors) (2021) Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts. Clinical Rheumatology, 40 (6). pp. 2277-2284. ISSN 0770-3198

Suresh, N. orcid.org/0000-0001-7431-3921, Karanth, R., Cheah, R. et al. (3 more authors) (2024) Systemic sclerosis and anorectal dysfunction: The Leeds experience. Journal of Scleroderma and Related Disorders, 9 (3). 210 -215. ISSN 2397-1983

T

Tachdjian, R., Savic, S. orcid.org/0000-0001-7910-0554, Fridman, M. et al. (3 more authors) (2022) REAL-WORLD TREATMENT BURDEN ASSOCIATED WITH PARENTERAL ON-DEMAND THERAPIES FOR HEREDITARY ANGIOEDEMA. In: Annals of Allergy, Asthma & Immunology. 2022 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology, 10-14 Nov 2022, Louisville, USA. Elsevier , S15-S16.

Tachdjian, R., Savic, S. orcid.org/0000-0001-7910-0554, Fridman, M. et al. (3 more authors) (2024) Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks. Allergy and Asthma Proceedings, 45 (1). pp. 37-43. ISSN 1088-5412

Tachdjian, R, Savic, S, Savic, S orcid.org/0000-0001-7910-0554 et al. (4 more authors) (2023) Reporting of Adverse Drug Reactions with Parenteral Drugs for the On-Demand Treatment of Hereditary Angioedema Attacks - Analysis of the FAERS Database 2009 to 2022. In: Journal of Allergy and Clinical Immunology. 2023 AAAAI Annual Meeting, 24-27 Feb 2023, San Antonio, TX, USA. Elsevier , AB144-AB144.

Tan, AL orcid.org/0000-0002-9158-7243, Buch, M orcid.org/0000-0002-8962-5642, O'Reilly, D et al. (5 more authors) (2017) 21st century state of rheumatoid arthritis management in the uk. In: Annals of the Rheumatic Diseases. Annual European Congress of Rheumatology, 14-17 Jun 2017, Madrid, Spain. BMJ Publishing Group , p. 786.

Tan, AL orcid.org/0000-0002-9158-7243, Fukuba, E, Halliday, NA et al. (3 more authors) (2015) High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis. Annals of the Rheumatic Diseases, 74 (1). pp. 185-189. ISSN 0003-4967

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis. Arthritis & Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

Tanaka, Y, McInnes, IB, Taylor, PC et al. (10 more authors) (2018) Characterization and changes of lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis: an integrated analysis. Arthritis and Rheumatology, 70 (12). pp. 1923-1932. ISSN 2326-5191

Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) Patients achieving sustained deep remission, deep remission or sustained remission of rheumatoid arthritis are more likely than other responders to maintain remission or low disease activity after dose reduction or withdrawal of etanercept. Arthritis Research and Therapy, 21. 164. ISSN 1478-6354

Tanaka, Y, Smolen, JS, Jones, H et al. (3 more authors) (2019) The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis. Arthritis Research & Therapy, 21 (1). 164. ISSN 1478-6354

Tarn, JR, Howard-Tripp, N, Lendrem, DW et al. (48 more authors) (2019) Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. The Lancet Rheumatology, 1 (2). e85-e94. ISSN 2665-9913

Taylor, CA, Watson, RA, Tong, O et al. (22 more authors) (2022) IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature Medicine, 28 (12). pp. 2592-2600. ISSN 1078-8956

Taylor, JC orcid.org/0000-0002-2518-5799, Bongartz, T, Massey, J et al. (37 more authors) (2018) Genome-wide Association Study of Response to Methotrexate in Early Rheumatoid Arthritis Patients. The Pharmacogenomics Journal, 18 (4). pp. 528-538. ISSN 1470-269X

Taylor, PC, Lee, YC, Fleischmann, R et al. (12 more authors) (2019) Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial. Journal of Clinical Medicine, 8 (6). 831. ISSN 2077-0383

Teenan, O., Kenaan, A., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (2 more authors) (2023) 1577 MicroRNA biomarkers in interstitial skin fluid for preclinical diagnosis of scleroderma. In: Journal of Investigative Dermatology. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), 10-13 May 2023, Tokyo, Japan. Elsevier , S270.

Temiz Karadağ, D., Gundogdu, O., Lettieri, G. et al. (5 more authors) (2020) AB0617 optical coherence tomography in the assessment of skin fibrosis in systemic sclerosis: a cross-sectional study. In: EULAR 2020 - Annual European Congress of Rheumatology, 03-06 Jun 2020, Virtual.

Thaventhiran, JED, Lango Allen, H, Burren, OS et al. (57 more authors) (2020) Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 583. pp. 90-95. ISSN 0028-0836

The RA-MAP Consortium (2022) RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients. Scientific data, 9 (1). 196. ISSN 2052-4463

Tillett, W, Helliwell, P, Fitzgerald, O et al. (13 more authors) (2020) AB0839 RELIABILITY OF COMPOSITE MEASURES FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS. In: EULAR 2020, 03-06 Jun 2020, Online.

Tillett, W., Coates, L., Kishimoto, M. et al. (4 more authors) (2022) 1268: Evaluating Numeric Rating Scale Versions of the 3 and 4 Visual Analog Scale (3/4-VAS) Composite Measures in Patients with Active Psoriatic Arthritis from the SELECT-PsA Program. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2488-2490.

Tillett, W., Coates, L., Kishimoto, M. et al. (4 more authors) (2022) AB0904 Evaluating Numeric Rating Scale Versions of the 3 and 4 Visual Analog Scale (3/4-VAS) Composite Measures in Patients with Active Psoriatic Arthritis from the SELECT-PsA Program. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 1580-1581.

Tillett, W., Coates, L., Neuhold, M. et al. (6 more authors) (2022) POS1043 Strong Correlation Between Short- Vs Long-Form Composite Measures Of Psoriatic Arthritis Disease Activity In A TNFi-IR Population Treated With Guselkumab: Data From The Phase 3b Cosmos Trial. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 838-839.

Tillett, W., Coates, L., Sharaf, M. et al. (7 more authors) (2022) 2142: Strong Correlation Between Short- vs Long-form Composite Measures ofPsoriatic Arthritis Disease Activity in a TNFi-IR Population Treated withGuselkumab: Data from the Phase 3b COSMOS Trial. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 4248-4251.

Tillett, W., Coates, L., Vis, M. et al. (9 more authors) (2023) P176 Minimal important difference, minimal detectable change and disease activity thresholds for two novel composite instruments, three visual analogue scale/VAS and four visual analogue scale/VAS, in patients with psoriatic arthritis: pooled analysis of three phase III studies. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Tillett, W., Coates, L., Vis, M. et al. (9 more authors) (2022) 1017: Minimal Important Difference (MID), Minimal Detectable Change (MDC),and Disease Activity Thresholds for Two Novel Composite Instruments(3VAS, 4VAS) in Patients with Psoriatic Arthritis: Pooled Analysis of ThreePhase 3 Studies. In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2013-2015.

Tillett, W., Coates, L., Vis, M. et al. (7 more authors) (2023) POS1535 Early improvement in 3VAS/4VAS predicts reduced rates of radiographic change in bio-naive active psoriatic arthritis patients receiving Guselkumab treatment. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Tillett, W.R., Coates, L., Vis, M. et al. (7 more authors) (2023) Early Improvement in 3 Visual Analogue Scale (3VAS)/4VAS Predicts Reduced Rates of Radiographic Change in Bio-naive Active Psoriatic Arthritis Patients Receiving Guselkumab Treatment. In: ACR Convergence 2023, 10-15 Nov 2023, San Diego, CA.

Tillett, W, Allen, A, Tucker, L et al. (17 more authors) (2020) Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Rheumatology. keaa526. ISSN 1462-0324

Tillett, W, Day, J, Mchugh, N et al. (3 more authors) (2021) Continuous Composite Measures for Routine Care in Psoriatic Arthritis: Thresholds of Meaning and Clinically Important Difference Estimates for the 3 and 4 VAS Scales from a UK Multicentre Study. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Tillett, W and Helliwell, P (2020) To Lump or Split When Assessing Psoriatic Arthritis — Not Mutually Exclusive? The Journal of Rheumatology, 47 (3). pp. 307-309. ISSN 0315-162X

Tinazzi, I, Mulipa, P, Colato, C et al. (6 more authors) (2021) SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker. Journal of Clinical Medicine, 10 (24). 5820. ISSN 2077-0383

Tom, BDM, Symmons, D, Brockbank, S et al. (145 more authors) (2018) Novel methodology to discern predictors of remission and patterns of disease activity over time using rheumatoid arthritis clinical trials data. RMD OPEN, 4 (2). e000721. ISSN 2056-5933

Topping, J., Chang, L., Nadat, F. et al. (17 more authors) (2024) Characterization of genetic landscape and novel inflammatory biomarkers in patients with adult-onset Still's disease. Arthritis & Rheumatology. ISSN 2326-5191

Topping, J., Poulter, J. orcid.org/0000-0003-2048-5693, Nadat, F. et al. (8 more authors) (2023) POS0236 ROLE OF NLRP3 INFLAMMASOME-DERIVED ASC SPECKS IN ADULT-ONSET STILL’S DISEASE. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ , pp. 350-351.

Torgutalp, M., Azevedo, V., Baraliakos, X. et al. (39 more authors) (2024) Characteristics of Patients with Psoriatic Arthritis Presenting with Axial Involvement: Results of a Prospective International Multicenter Study (AXIS). In: ACR Convergence 2024, 14-19 Nov 2024, Washington, D. C..

Tornling, G., Edenius, C., Pauling, J.D. et al. (16 more authors) (2024) A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's. Rheumatology. keae049. ISSN 1462-0324

Traylor, M, Knevel, R, Cui, J et al. (17 more authors) (2019) Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases. PLoS ONE, 14 (10). ARTN: e022. ISSN 1932-6203

Tucker, L, Allen, A, Chandler, D et al. (16 more authors) (2022) The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology. ISSN 1462-0324

Tucker, L, Allen, A, Chandler, D et al. (16 more authors) (2022) Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology. keac260. ISSN 1462-0324

Tucker, L, Helliwell, P orcid.org/0000-0002-4155-9105, Coates, L et al. (1 more author) (2021) Which composite measure best reflects disease activity and predicts treatment change in psoriatic arthritis? In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Tucker, LJ, Coates, LC and Helliwell, PS (2019) Assessing Disease Activity in Psoriatic Arthritis: A Literature Review. Rheumatology and Therapy, 6 (1). pp. 23-32. ISSN 2198-6576

Turro, E, Astle, WJ, Megy, K et al. (60 more authors) (2020) Whole-genome sequencing of patients with rare diseases in a national health system. Nature, 583. pp. 96-102. ISSN 0028-0836

Tuttle, J, Drescher, E, Simón-Campos, JA et al. (7 more authors) (2023) A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. New England Journal of Medicine, 388 (20). pp. 1853-1862. ISSN 0028-4793

V

Van Nieuwenhove, E, De Langhe, E, Dooley, J et al. (10 more authors) (2021) Phenotypic analysis of pyrin-associated autoinflammation with neutrophilic dermatosis patients during treatment. Rheumatology. ISSN 1462-0324

Velauthapillai, A., Bootsma, M.F.R., Bruni, C. et al. (118 more authors) (2024) Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. Rheumatology. keae375. ISSN 1462-0324

Verardi, L., De Lorenzis, E., Pellegrino, G. et al. (19 more authors) (2023) POS1324 mycophenolate mofetil use in clinical practice in a multicentric cohort of scleroderma patients: persistence on therapy and long-term adverse events. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Vital, EM orcid.org/0000-0003-1637-4755, Wittmann, M orcid.org/0000-0003-2328-4926, Edward, S et al. (5 more authors) (2015) Brief report: Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus. Arthritis and Rheumatology, 67 (6). pp. 1586-1591. ISSN 2326-5191

Volkmann, ER, Sparks, JA, Hoffmann-Vold, A-M et al. (3 more authors) (2023) Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences. The Lancet Rheumatology, 5 (3). e116-e118. ISSN 2665-9913

van Laar, JM, Farge, D, Sont, JK et al. (42 more authors) (2014) Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial. Journal of the American Medical Association, 311 (24). pp. 2490-2498. ISSN 0098-7484

van Ouwerkerk, L, Boers, M, Emery, P orcid.org/0000-0002-7429-8482 et al. (8 more authors) (2023) Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 82 (4). pp. 468-475. ISSN 0003-4967

van der Heijde, D, Schiff, M, Tanaka, Y et al. (6 more authors) (2019) Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis. RMD Open, 5 (1). e000898. ISSN 2056-5933

W

Walker, D, Robinson, S, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (1 more author) (2020) Development and validation of a bi-lingual interactive tool to educate people about osteomalacia. Musculoskeletal Care, 18 (3). pp. 265-270. ISSN 1478-2189

Walker, K orcid.org/0000-0002-6694-2979, Mistry, A, Watson, CM et al. (9 more authors) (2023) Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12. Journal of Clinical Immunology, 43. pp. 1543-1556. ISSN 0271-9142

Wanat, M, Santillo, M, Galal, U et al. (10 more authors) (2022) Mixed-methods evaluation of a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice. BMJ Open, 12 (6). e057471. ISSN 2044-6055

Wang, C, Sun, B, Wu, K et al. (29 more authors) (2022) Clinical, Immunological Features, Treatments, and Outcomes of Autoimmune Hemolytic Anemia in Patients with RAG Deficiency. In: Blood. 64th ASH Annual Meeting, 10-13 Dec 2022, New Orleans, USA. American Society of Hematology , pp. 2448-2450.

Wasson, C., Clavane, E., Ross, R. et al. (7 more authors) (2023) OP0113 The Beta Secretase Bace1 Drives Systemic Sclerosis Fibroblasts Activation Through Β-Catenin And Notch Signalling. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 75.

Wasson, C., Dibb, S., Bryon, J. et al. (8 more authors) (2024) P27 Chloride intracellular channel 4 is a global regulator of type 1 interferon signalling in systemic sclerosis skin. British Journal of Dermatology, 190 (6). e91-e92. ISSN 0007-0963

Wasson, C., Ross, R., Wells, R. et al. (4 more authors) (2020) Long Non-coding RNA HOTAIR Induces GLI2 Expression Through Notch Signalling in Systemic Sclerosis Dermal Fibroblasts. Arthritis Research & Therapy, 22. 286. ISSN 1478-6354

Wasson, C.W., Abignano, G. orcid.org/0000-0002-1479-0133, Ross, R. et al. (1 more author) (2020) O30 Long non-coding RNA HOTAIR induces beta catenin expression in systemic sclerosis through EZH2 dependent repression of Axin-2. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press , ii14.

Watad, A, De Marco, G orcid.org/0000-0003-2406-161X, Mahajna, H et al. (23 more authors) (2021) Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination. Vaccines, 9 (5). ISSN 2076-393X

Watad, A, Kacar, M, Bragazzi, NL et al. (10 more authors) (2021) Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication. Frontiers in Immunology, 12. p. 610019. ISSN 1664-3224

Watson, C.M. orcid.org/0000-0003-2371-1844, Nadat, F., Ahmed, S. et al. (4 more authors) (2022) Identification of a novel MAGT1 mutation supports a diagnosis of XMEN disease. Genes and Immunity, 23. pp. 66-72. ISSN 1466-4879

Watson, L., Coyle, C., Brooke, M. et al. (25 more authors) (2023) Current prescribing practices in psoriatic arthritis - comparison between the UK and Europe. In: British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester - Hybrid.

Watson, L.L., Coyle, C., Brooke, M. et al. (25 more authors) (2023) P179 Shared decision-making in psoriatic arthritis consultations. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Wells, A.F., Kavanaugh, A., Tillett, W. et al. (7 more authors) (2024) Value of the Routine Assessment of Patient Index Data 3 in Assessing Disease Severity and Treatment Effect in Patients with Early Oligoarticular Psoriatic Arthritis Treated with Apremilast. In: Arthritis & Rheumatology. ACR Convergence 2024, 14-19 Nov 2024, Washington, DC, USA. Wiley , pp. 1213-1215.

Westhovens, R. orcid.org/0000-0002-3432-3073, Winthrop, K.L. orcid.org/0000-0002-3892-6947, Kavanaugh, A. orcid.org/0000-0001-6942-5830 et al. (11 more authors) (2025) Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study. RMD Open: Rheumatic and Musculoskeletal Diseases, 11 (1). e004857. ISSN 2056-5933

Whitehouse, H, Savic, S orcid.org/0000-0001-7910-0554 and Laws, P (2020) Tofacitinib: a novel treatment for multicentric reticulohistiocytosis. In: British Association of Dermatologists 100th Annual Meeting, 01 Sep - 02 Nov 2020, Online.

Whitworth, J, Smith, PS, Martin, J-E et al. (41 more authors) (2018) Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. American Journal of Human Genetics, 103 (1). pp. 3-18. ISSN 0002-9297

Williams, AE, Cherry, L, Blake, A et al. (5 more authors) (2016) An Investigation into the Scale and Impact of Self-Reported Foot Problems Associated with Systemic Lupus Erythematosus: A Study Protocol and Survey Questionnaire Development. Musculoskeletal Care, 14 (2). pp. 110-115. ISSN 1478-2189

Winter, E., Dekkers, O., Andreasen, C. et al. (37 more authors) (2024) 2024 Clinical Practice Guideline for the Diagnosis and Treatment of Chronic Nonbacterial Osteitis (CNO) in Adults. In: 2024 Annual Meeting of the American Society for Bone and Mineral Research, 27-30 Sep 2024, Toronto, Canada.

Wouters, F, Maurits, MP, Van Boheemen, L et al. (9 more authors) (2021) Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Wu, B, Rice, L, Shrimpton, J et al. (9 more authors) (2021) Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder. eLife, 10. e72559. ISSN 2050-084X

Wu, KY, Purswani, P, Ujhazi, B et al. (10 more authors) (2019) Arthritis in Two Patients With Partial Recombination Activating Gene Deficiency. Frontiers in Pediatrics, 7. 235. ISSN 2296-2360

Wyss, A., Jordan, S., Graf, N. et al. (18 more authors) (2024) Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis. Arthritis Research & Therapy, 26. 187. ISSN 1478-6354

X

Xie, X, Doody, GM, Shuweihdi, F et al. (2 more authors) (2023) B-cell capacity for expansion and differentiation into plasma cells are altered in osteoarthritis. Osteoarthritis and Cartilage, 31 (9). pp. 1176-1188. ISSN 1063-4584

Xie, X orcid.org/0000-0002-1474-9931, Shrimpton, J, Doody, GM orcid.org/0000-0003-0665-6759 et al. (2 more authors) (2021) B-cell capacity for differentiation changes with age. Aging Cell, 20 (4). e13341. ISSN 1474-9718

Xie, X orcid.org/0000-0002-1474-9931, van Delft, MAM, Shuweihdi, F orcid.org/0000-0003-1199-2992 et al. (5 more authors) (2021) Auto-antibodies to post-translationally modified proteins in osteoarthritis. Osteoarthritis and Cartilage, 29 (6). pp. 924-933. ISSN 1063-4584

Xu, C, Rafique, A, Potocky, T et al. (12 more authors) (2021) Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters. The Journal of Clinical Pharmacology, 61 (5). pp. 714-724. ISSN 0091-2700

Xu, L., Jones, G., Rotariu, O. et al. (4 more authors) (2024) Predictors of Work Impairment and Absence Amongst People with Psoriatic Arthritis (PsA) - Evidence from the British Society for Rheumatology PsA Register (BSR-PsA). In: ACR Convergence 2024, 14-19 Nov 2024, Washington, D. C..

Y

Yazji, S., Helliwell, P., Balanescu, A. et al. (13 more authors) (2022) 1496: Do Patients in MDA Report Low Disease Activity Regardless of Which of the MDA Criteria Are Met? In: Arthritis & Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 2954-2957.

Yazji, S.M., Helliwell, P.S. orcid.org/0000-0002-4155-9105, Balanescu, A. et al. (9 more authors) (2025) Association between patient perception of disease status and different components of the Minimal Disease Activity (MDA) criteria in psoriatic arthritis. The Journal of Rheumatology. ISSN 0315-162X

Ye, W, Hackett, S, Vandevelde, C et al. (3 more authors) (2020) Comparing the visual analogue scale (VAS) and the numerical rating scale (NRS) in patient reported outcomes in psoriatic arthritis. The Journal of Rheumatology. jrheum.200. ISSN 0315-162X

Yea, C., Audhya, P., Williams, P. et al. (1 more author) (2021) P052 relationship between PGI-C scale and other pros in KVD900 trial in HAE. In: 2021 Annual Scientific MeetingAmerican College of Allergy, Asthma & Immunology, 04-08 Nov 2021, New Orleans, Louisiana.

Yusof, MYM, Iqbal, K, Darby, M et al. (6 more authors) (2020) Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis. Rheumatology. ISSN 1462-0324

Yusof, MYM, Vital, EM orcid.org/0000-0003-1637-4755, Emery, P orcid.org/0000-0002-7429-8482 et al. (1 more author) (2020) Response to “Increased awareness of hypogammaglobulinemia after B‐cell targeting therapies” by Karim MY. Arthritis & Rheumatology, 72 (7). pp. 1231-1233. ISSN 2326-5191

Yusof, YM, Arnold, J, Saleem, B et al. (5 more authors) (2022) Breakthrough SARS-CoV-2 Infections and Predicting Severe Outcomes During Rituximab Therapy in Autoimmune Rheumatic Diseases. In: Arthritis and Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 1559-1560.

Z

Zayat, AS, Mahmoud, K, Md Yusof, MY orcid.org/0000-0003-3131-9121 et al. (4 more authors) (2016) A Prospective Study To Assess Responsiveness of Clinical and Ultrasound Outcome Measures for Musculoskeletal Sle. In: Annals of the Rheumatic Diseases. Annual European Conference of Rheumatology: EULAR 2016, 08-11 Jun 2016, London, UK. BMJ Publishing Group , p. 549.

Zayat, AS, Mahmoud, K, Yusof, MYM et al. (8 more authors) (2019) Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus. Rheumatology, 58 (2). key277. pp. 304-312. ISSN 1462-0324

Zheng, B. orcid.org/0000-0003-2509-5766, Wang, M., McKenna, K. et al. (16 more authors) (2022) Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis. Arthritis Care & Research, 74 (11). pp. 1806-1812. ISSN 2151-464X

Zhou, Q, Wang, K, Rahman, L et al. (4 more authors) (2020) Undiagnosed rheumatic disease in newly presenting MGUS patient. In: EULAR 2020, 03-06 Jun 2020, Online.

Á

Álvarez Hernández, M. P., Allanore, Y., Andrade, I. et al. (9 more authors) (2024) E061 Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: a survey of UK-based rheumatologists. In: British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool.

Álvarez-Hernández, M.P. orcid.org/0000-0002-9972-1312, Allanore, Y., Andrade, I. et al. (9 more authors) (2024) Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists. Journal of Scleroderma and Related Disorders. ISSN 2397-1983